AGREEMENTS, TREATIES AND PATENT FILING PROCEDURES

[Link] (ppt)
[Link] (FREQUENTLY ASKED QUESTIONS)
History of GATT Agreement – Madrid Agreement – Hague Agreement – WIPO Treaties – Budapest Treaty
– PCT – Ordinary – PCT – Conventional – Divisional and Patent of Addition – Specifications – Provisional
and complete – Forms and fees Invention in context of “prior art” – Patent databases – Searching
International Databases – Country-wise patent searches (USPTO,espacenet(EPO) – PATENT Scope
(WIPO) – IPO, etc National & PCT filing procedure – Time frame and cost – Status of the patent
applications filed – Precautions while patenting – disclosure/non-disclosure – Financial assistance for
patenting – Introduction to existing schemes Patent licensing and agreement Patent infringement –
Meaning, scope, litigation, case studies
HISTORY OF GATT AGREEMENT
The General Agreement on Tariffs and Trade (GATT), signed in 1947 by 23 countries, is a treaty
minimizing barriers to international trade by eliminating or reducing quotas, tariffs, and subsidies. It was
intended to boost economic recovery after World War II World Trade Organization. “The Text of the
General Agreement on Tariffs and Trade.”GATT was expanded and refined over the years, leading to the
creation in 1995 of the World Trade Organization (WTO), which absorbed the organization created to
implement GATT. By then, 125 nations were signatories to its agreements, which covered about 90% of
global trade.12
The Council for Trade in Goods (known as the Goods Council) is now responsible for GATT and consists
of representatives from all WTO member countries. The chairperson of the Goods Council is Ambassador
Clare Kelly of New Zealand. The council has 10 committees that address subjects including market access,
agriculture, subsidies, and anti-dumping measures.34
Key Takeaways
• The General Agreement on Tariffs and Trade (GATT) was signed by 23 countries in October 1947,
after World War II, and became law on Jan. 1, 1948.
• The purpose of GATT was to make international trade easier.
• Its goal was to eliminate undesirable trade aspects of the prewar period.
• GATT held eight rounds of trade negotiations in total, from April 1947 to December 1993, and each
had significant achievements and outcomes.5
• In 1995, GATT was absorbed into the World Trade Organization (WTO), which extended it.
History of the GATT
GATT held eight rounds of meetings—the first beginning in April 1947, the last ending in December 1993.
Each of the conferences had significant achievements and outcomes.
• The first meeting was in Geneva, Switzerland, and included 23 countries. The focus of this opening
conference was on tariffs. The members established tax concessions affecting more than US$10
billion of trade around the globe.5
• The second series of meetings began in April 1949 and was held in Annecy, France. Again, tariffs
were the primary topic. Thirteen countries were at the second meeting, and they accomplished an
additional 5,000 tax concessions reducing tariffs.57
 • Starting in September 1950, the third series of GATT meetings occurred in Torquay, England. This
time, 38 countries were involved and almost 9,000 tariff concessions passed, reducing tax levels by
as much as 25%.7
• Japan became involved in GATT for the first time in 1956 at the fourth meeting along with 25 other
countries.8 The meeting was in Geneva, and again the committee reduced worldwide tariffs, this
time by US$2.5 billion.5
This series of meetings and tariff reductions would continue, resulting in new GATT provisions in the
process. In 1964, GATT began to work toward curbing predatory pricing policies (known as dumping).
Then in the 1970s, an arrangement regarding international trade in textiles, known as the Multifibre
Arrangement (MFA), came into force. The next big event was the Uruguay Round, which lasted from 1986
to 1993, with the agreements signed in 1994, and which created the WTO.5
World Trade Organization. “Fiftieth Anniversary of the Multilateral Trading System.”
Purpose of the General Agreement on Tariffs and Trade (GATT)
The General Agreement on Tariffs and Trade was set up to eliminate protectionism, get countries trading
freely among themselves, and help restore economic prosperity following the devastation of World War II.
Understanding the General Agreement on Tariffs and Trade (GATT)
GATT was created to form rules to end or restrict the most costly and undesirable features of the prewar
protectionist period, namely quantitative trade barriers such as trade controls and quotas.
The agreement also provided a system by which to arbitrate commercial disputes among nations. The
framework enabled a number of multilateral negotiations for the reduction of tariff barriers. GATT was
regarded as a significant success in the postwar years.
Equal Treatment of Nations in Trade
One of the key achievements of GATT was that of trade without discrimination. Every signatory member
of GATT was to be treated as equal to any other. This is known as the most-favored-nation principle, and
it was carried through into the WTO.
A practical outcome of this was that once a country had negotiated a tariff cut with some other countries
(usually its most important trading partners), this same cut would automatically apply to all GATT
signatories. Escape clauses did exist, whereby countries could negotiate exceptions if their domestic
producers would be particularly harmed by tariff cuts.16
Most nations adopted the most-favored-nation principle in setting tariffs, which largely replaced quotas.
Tariffs (preferable to quotas but still a trade barrier) were, in turn, cut steadily in successive rounds of
negotiations.
MADRID SYSTEM
More than a century ago, nine countries established a special Union for the International Registration of
Marks, at present known as the Madrid system. Since then, the Madrid system has expanded and evolved
to meet the ever-changing business needs. More and more countries have signed up for this unique
international trademark registration system administered by the World Intellectual Property Organization
(WIPO), a UN specialized agency based in Geneva, Switzerland. The Madrid system has helped businesses
register and protect millions of marks worldwide.
There are two treaties that govern the system: the Madrid agreement of 1891 and the Madrid protocol of
1989. Its provisions made the Madrid system more modern and flexible, and have led to its global
expansion. Through the Madrid system, WIPO offers centralized registration and management of
international trademarks. Rather than having to file numerous applications for each separate export market,
with the Madrid system, an enterprise needs to file only one application in one language at one national or
regional trademark office by paying through one currency. It provides a fast, efficient, and cost-effective
way for small, medium, or large enterprises to protect their marks in the countries and organizations that
are
International trademark registration process under Madrid system
STAGE 1 – Application at National/ Regional IP office
The first stage is to file an application at the national level at the applicant’s “home” IP office. This
application is referred to as ‘basic mark’. The international application is submitted through the same
regional IP office to WIPO, after the certification process by the home IP office.
STAGE 2- Formal Examination by WIPO
WIPO formally examines the application and initiates the process of approval. After the approval, the
applicant’s mark is recorded in the International register (WIPO Gazette of International Marks). WIPO
then issues a certificate of the international registration and accordingly notifies the respective countries
where the applicant desires to protect his mark.
STAGE 3- Substantive examination by Each designated country’s regional IP office-
The IP offices of the countries where the applicant wants to protect his mark would substantively examine
the application within 12 to 18 months as per the applicable laws of their country. WIPO then records the
final decisions of these offices and accordingly notify the applicant.

Fee Structure
Under the Madrid Protocol, payment of official fees is a simple process. An applicant has to pay through
one centralized window rather than having to wire funds all over the world. These fees are calculated on a
per-country basis. There is a basic fee payable for the actual application, it's either 653 Swiss francs, or
903, Swiss francs, depending on whether the mark needs to be reproduced in color or not. Adding to the
basic fee there is a supplementary fee of 100 Swiss francs for each class of goods and services beyond
three classes, and there's also a complimentary fee for each contracting party designated. This
complimentary fee is either 100 Swiss francs or some other amount as requested by each country.

Who can avail benefits of the Madrid Protocol?

All the countries that are signatory to the Madrid Agreement or Madrid Protocol are collectively known as
the Madrid Union. An enterprise seeking to avail the benefit under this Protocol needs to have its business
situated in one of the 122 countries of the Madrid Union. For example, X has a business incorporated in
the US and wants to trademark his brand in the US, Canada, France, Sweden, Russia, Australia, Mexico,
Brazil, China, and India. For that, it needs to first file a direct trademark application in the US, known as
the basic or national application, and then file the international trademark application for countries Canada,
Russia, Australia, Mexico, Brazil, China, and India.
Filing of international trademark where a country is not a part of the Madrid Union-
Companies that have a formal business presence in the countries which are not part of the Madrid Union,
cannot file a direct international trademark application For instance, Nepal is not a part of the Madrid
Union while India is. A Nepalese company X sells its product to India and wants to obtain a trademark for
the same in India. In the above instance, X can’t obtain a trademark over its product in India through the
Madrid system. To obtain the trademark of the product company X has to separately apply to the regional
IP office in Nepal and fulfill the criteria listed under Nepalese local law.
A country that is a part of the Madrid Union cannot obtain a trademark over its product in a country that is
not a part of the Madrid Union through Madrid protocol. For instance, an Indian company won’t be able
to obtain a trademark over its product in Nepal through the Madrid application. The Indian company needs
to separately apply to Nepalese firms in order to get it.
Advantages of the Madrid System-
1. Makes the process of Obtaining trademark protection in several countries easier and cost-effective.
2. Only one application needs to be filed. This saves time and efforts which would otherwise be spent
on going through different trademark regulations in each country to file the application.
3. The protocol allows the international application to be filed in English, Spanish or French. Thus, it
reduces the need to translate the trademark application to numerous different languages, as not
every country recognizes English/Spanish/French as its official language.
4. It allows a company to obtain a trademark in any or all member states of the protocol by filing a
single application in one jurisdiction with one single payment of fees and make any alterations and
renew the registration across all applicable jurisdictions through a single administrative process.
Limitations of the Madrid System:
1. International Madrid application and registrations are heavily dependent on the national application
or registration. This means that if the home application or registration is amended, denied,
withdrawn, or canceled during the five years following the international registration date, the
associated international applications and registrations are treated the same way. This is usually
referred to as a ‘central attack’. This dependency lasts for the first five years after the issuance of
the international registration. Once the international registration has been in effect for over five
years, it becomes independent from the basic registration.
2. The international application is examined by each national trademark office separately, and if they
issue objections, a local agent is needed to address the possible objections.
3. If an applicant at the national level is rejected then the international application based on that flawed
direct application would also fail. Sometimes companies may want to wait for their home
application to clear the opposition period, so as to make sure no central attack is started against
them. However, when it comes to new brands\ it may become a problem as waiting until after the
opposition period would cause them to lose the advantage of the conventional priority. This priority
allows them to claim the date of your international application, back to the filing date of their home
application. The reason behind it is that in order to take advantage of the conventional priority, you
have to file your international application within a six-month window after filing your basic
application and the opposition period usually takes longer than the six-month window.
As new countries are joining the Madrid system it has become more efficient than it has ever been, it has
a bright future ahead as the global system for the International Registration of Marks. The Madrid system
can be said to be the number one solution for international trademark registration.
HAGUE AGREEMENT
Two Acts of the Hague Agreement are currently in operation – the 1999 Act and the 1960 Act. In
September 2009, it was decided to freeze the application of the 1934 Act of the Hague Agreement, thus
simplifying and streamlining overall administration of the international design registration system.
An international design registration may be obtained only by a natural person or legal entity having a
connection – through establishment, domicile, nationality or, under the 1999 Act, habitual residence – with
a Contracting Party to either of the two Acts.
The Hague Agreement allows applicants to register an industrial design by filing a single application with
the International Bureau of WIPO, enabling design owners to protect their designs with minimum
formalities in multiple countries or regions. The Hague Agreement also simplifies the management of an
industrial design registration, since it is possible to record subsequent changes and to renew the
international registration through a single procedural step.
An international application may be governed by the 1999 Act, the 1960 Act or both, depending on the
Contracting Party with which the applicant has the connection described above (hereafter referred to as
"Contracting Party of origin").
International design applications may be filed with the International Bureau of WIPO, either directly or
through the industrial property office of the Contracting Party of origin if the law of that Contracting Party
so permits or requires. In practice, however, virtually all international applications are filed directly with
the International Bureau, and the majority are filed using the electronic filing interface on WIPO's website.
International applications may include up to 100 designs, provided they all belong to the same class of the
International Classification for Industrial Designs (Locarno Classification). Applicants may choose to file
an application in English, French or Spanish. International applications must contain one or several
reproductions of the industrial design(s) and must designate at least one Contracting Party.
International registrations are published in the International Designs Bulletin, issued weekly online.
Depending on the Contracting Parties designated, applicants may request that the publication be deferred
by a period not exceeding 30 months from the date of the international registration or, if priority is claimed,
from the priority date.
Each Contracting Party designated by the applicant may refuse protection within 6 months, or possibly
12 months under the 1999 Act, from the date of publication of the international registration. Refusal of
protection can only be based on requirements of the domestic law other than the formalities and
administrative acts to be accomplished under the domestic law by the office of the Contracting Party that
refuses protection.
If no refusal is notified by a given designated Contracting Party within the prescribed time limit (or if such
refusal has subsequently been withdrawn), the international registration has effect as a grant of protection
in that Contracting Party, under the law of that Contracting Party.
The term of protection is five years, renewable for at least one five-year period under the 1960 Act, or two
such periods under the 1999 Act. If the legislation of a Contracting Party provides for a longer term of
protection, protection of the same duration shall, on the basis of the international registration and its
renewals, be granted in that Contracting Party to designs that have been the subject of an international
registration. To facilitate access to the Hague system for design creators from least developed countries
(LDCs), the fees for an international application are, in their case, reduced to 10 per cent of the prescribed
amounts.
The 1934 Act
The application of the 1934 Act was frozen as of January 1, 2010, meaning that no new registration or
designation under the 1934 Act could be entered in the International Register as of that date. However, the
renewal of existing designations under the 1934 Act and the recording in the International Register of any
change affecting such designations will continue to be possible up to the maximum duration of protection
under the 1934 Act (15 years).
General
The WIPO Secretariat publishes a Guide to the International Registration of Industrial Designs for users
of the Hague system.
The Hague Agreement, concluded in 1925, was revised at London in 1934 and at The Hague in 1960. It
was completed by an Additional Act signed at Monaco in 1961 and by a Complementary Act signed at
Stockholm in 1967, which was amended in 1979. As noted above, a further Act was adopted at Geneva in
1999.
The Hague Agreement created a Union, which, since 1970, has had an Assembly. Every member of the
Union that has adhered to the Complementary Act of Stockholm is a member of the Assembly. Among the
most important tasks of the Assembly are the adoption of the biennial program and budget of the Union
and the adoption and modification of the implementing regulations, including the fixing of the fees
connected with the use of the Hague system.
The 1999 Act of the Agreement is open to any WIPO Member State and to certain intergovernmental
organizations. Instruments of ratification or accession must be deposited with the Director General of
WIPO. While the 1960 Act remains open to States party to the Paris Convention for the Protection of
Industrial Property (1883), it is the more advantageous 1999 Act that governments of prospective
Contracting Parties are encouraged to join.

WIPO TREATIES
The WIPO Copyright Treaty (WCT) is a special agreement under the Berne Convention that deals with the
protection of works and the rights of their authors in the digital environment. Any Contracting Party (even
if it is not bound by the Berne Convention) must comply with the substantive provisions of the 1971 (Paris)
Act of the Berne Convention for the Protection of Literary and Artistic Works (1886). Furthermore, the
WCT mentions two subject matters to be protected by copyright: (i) computer programs, whatever the
mode or form of their expression; and (ii) compilations of data or other material ("databases"), in any form,
which, by reason of the selection or arrangement of their contents, constitute intellectual creations. (Where
a database does not constitute such a creation, it is outside the scope of this Treaty.)
As to the rights granted to authors, apart from the rights recognized by the Berne Convention, the Treaty
also grants: (i) the right of distribution; (ii) the right of rental; and (iii) a broader right of communication
to the public.
• The right of distribution is the right to authorize the making available to the public of the original
and copies of a work through sale or other transfer of ownership.
• The right of rental is the right to authorize commercial rental to the public of the original and
copies of three kinds of works: (i) computer programs (except where the computer program itself
is not the essential object of the rental); (ii) cinematographic works (but only in cases where
commercial rental has led to widespread copying of such works, materially impairing the exclusive
right of reproduction); and (iii) works embodied in phonograms as determined in the national law
of Contracting Parties (except for countries which, since April 15, 1994, have had a system in force
for equitable remuneration of such rental).
• The right of communication to the public is the right to authorize any communication to the
public, by wire or wireless means, including "the making available to the public of works in a way
that the members of the public may access the work from a place and at a time individually chosen
by them". The quoted expression covers, in particular, on-demand, interactive communication
through the Internet.
As to limitations and exceptions, Article 10 of the WCT incorporates the so-called "threestep" test to
determine limitations and exceptions, as provided for in Article 9(2) of the Berne Convention, extending
its application to all rights. The Agreed Statement accompanying the WCT provides that such limitations
and exceptions, as established in national law in compliance with the Berne Convention, may be extended
to the digital environment. Contracting States may devise new exceptions and limitations appropriate to
the digital environment. The extension of existing or the creation of new limitations and exceptions is
allowed if the conditions of the "three-step" test are met.
As to duration, the term of protection must be at least 50 years for any kind of work.
The enjoyment and exercise of the rights provided for in the Treaty cannot be subject to any formality.
The Treaty obliges Contracting Parties to provide legal remedies against the circumvention of
technological measures (e.g., encryption) used by authors in connection with the exercise of their rights,
and against the removal or altering of information, such as certain data that identify works or their authors,
necessary for the management (e.g., licensing, collecting and distribution of royalties) of their rights
("rights management information").
The Treaty obliges each Contracting Party to adopt, in accordance with its legal system, the measures
necessary to ensure the application of the Treaty. In particular, each Contracting Party must ensure that
enforcement procedures are available under its law so as to permit effective action against any act of
infringement of rights covered by the Treaty. Such action must include expeditious remedies to prevent
infringement as well as remedies that constitute a deterrent to further infringement.
The Treaty establishes an Assembly of the Contracting Parties whose main task is to address matters
concerning the maintenance and development of the Treaty. It entrusts to the Secretariat of WIPO the
administrative tasks concerning the Treaty.
The Treaty was concluded in 1996 and entered into force in 2002.
The Treaty is open to States members of WIPO and to the European Community. The Assembly constituted
by the Treaty may decide to admit other intergovernmental organizations to become party to the Treaty.
Instruments of ratification or accession must be deposited with the Director General of WIPO.
BUDAPEST TREATY
The budapest treaty on the international recognition of the deposit of microorganisms for the purposes
of patent procedure (1977)
The main feature of the Treaty is that a contracting State which allows or requires the deposit of
microorganisms for the purposes of patent procedure must recognize, for such purposes, the deposit of a
microorganism with any "international depositary authority", irrespective of whether such authority is on
or outside the territory of the said State.
Disclosure of the invention is a requirement for the grant of patents. Normally, an invention is disclosed
by means of a written description. Where an invention involves a microorganism or the use of a
microorganism, disclosure is not possible in writing but can only be effected by the deposit, with a
specialized institution, of a sample of the microorganism. In practice, the term “microorganism” is
interpreted in a broad sense, covering biological material the deposit of which is necessary for the purposes
of disclosure, in particular regarding inventions relating to the food and pharmaceutical fields.
It is in order to eliminate the need to deposit in each country in which protection is sought, that the Treaty
provides that the deposit of a microorganism with any "international depositary authority" suffices for the
purposes of patent procedure before the national patent offices of all of the contracting States and before
any regional patent office (if such a regional office declares that it recognizes the effects of the Treaty).
The European Patent Office (EPO), the Eurasian Patent Organization (EAPO), the African Intellectual
Property Organization (OAPI) and the African Regional Intellectual Property Organization (ARIPO) have
made such declarations.
What the Treaty calls an "international depositary authority" is a scientific institution - typically a "culture
collection" - which is capable of storing microorganisms. Such an institution acquires the status of
"international depositary authority" through the furnishing by the contracting State in the territory of which
it is located of assurances to the Director General of WIPO to the effect that the said institution complies
and will continue to comply with certain requirements of the Treaty.
On April 25, 2024 there were 50 such authorities: seven in the United Kingdom, four in the Republic of
Korea, three in China, India, Italy, Poland and the United States of America, two each in Australia, Japan,
the Russian Federation and Spain, and one each in Belgium, Bulgaria, Canada, Chile, the Czech Republic,
Finland, France, Germany, Hungary, Latvia, Mexico, Morocco, the Netherlands (Kingdom of the),
Portugal, Slovakia and Switzerland.
The Treaty makes the patent system of the contracting State more attractive because it is primarily
advantageous to the depositor if he is an applicant for patents in several contracting States; the deposit of
a microorganism under the procedures provided for in the Treaty will save him money and increase his
security. It will save him money because, instead of depositing the microorganism in each and every
contracting State in which he files a patent application referring to that microorganism, he will deposit it
only once, with one depositary authority. The Treaty increases the security of the depositor because it
establishes a uniform system of deposit, recognition and furnishing of samples of microorganisms.
The Treaty does not provide for the institution of a budget but it does create a Union and an Assembly
whose members are the States which are party to the Treaty. The main task of the Assembly is the
amendment of the Regulations issued under the Treaty. No State can be requested to pay contributions to
the International Bureau of WIPO on account of its membership in the Budapest Union or to establish an
"international depositary authority".
The Budapest Treaty was concluded in 1977.
The Treaty is open to States party to the Paris Convention for the Protection of Industrial Property (1883).
Instruments of ratification or accession must be deposited with the Director General of WIPO.
THE PATENT COOPERATION TREATY (PCT) (1970)
The Patent Cooperation Treaty (PCT) makes it possible to seek patent protection for an invention
simultaneously in over 150 countries by filing an "international" patent application. Such an application
may be filed by a national or resident of a PCT Contracting State. It may generally be filed with the national
patent office of the Contracting State of which the applicant is a national or resident or with the
International Bureau of WIPO.
If the applicant is a national or resident of a Contracting State party to a regional patent treaty the member
States of which are PCT Contracting States, the international application may also be filed with the regional
patent office set up under such a treaty.
The PCT regulates in detail the formal requirements with which international applications must comply.
Filing an international application has the same legal effect as filing a national application with the national
patent office of each PCT Contracting State.
The international application is subjected to an international search. That search is carried out by one of
the competent International Searching Authorities (ISA) under the PCT [1] and results in an international
search report which lists published documents that are considered closest to and might affect the
patentability of the invention claimed in the international application. In addition, the ISA issues a
preliminary and non-binding written opinion on whether the claimed invention appears to meet
patentability criteria in light of the search results.
The international search report and written opinion are communicated to the applicant. After evaluating
their content, the applicant may decide to withdraw the application, in case the report and opinion suggest
that the granting of patents is unlikely. The applicant may also decide to amend the claims in the
application.
If the international application is not withdrawn, it is published by the International Bureau together with
the international search report. In most cases, the written opinion is made publicly available
on PATENTSCOPE.
Before the expiration of 22 months from the priority date, the applicant has the option to request another
International Searching Authority (any of the other ISAs willing to offer this service) to carry out an
additional search in the particular language used by that authority or technical fields in which that authority
specializes. The goal of this additional search (called Supplementary International Search) is to reduce the
likelihood of further documents coming to light in the national phase that would make the granting of a
patent unlikely.
An applicant who decides to continue with the international application with a view to seeking national (or
regional) patents can typically wait until close to the end of the thirtieth month from the priority date to
commence the national procedure before each designated office. To commence the national procedure, the
applicant must furnish a translation (where necessary) of the application into the official language of that
office, pay the necessary fees and appoint a local patent agent if required.
If the applicant wishes to make amendments to the application – for example, to address any negative
findings in the search report and the written opinion – or to have the potential patentability of the "as-
amended" application reviewed – an optional international preliminary examination may be requested. The
result of the preliminary examination is an international preliminary report on patentability (IPRP
Chapter II) which is prepared by one of the competent International Preliminary Examining
Authorities (IPEA) under the PCT and which contains a preliminary and non-binding opinion on the
patentability of the claimed invention. It provides the applicant with an even stronger basis on which to
evaluate the chances of obtaining a patent and, if the report is favorable, a stronger basis on which to
continue with the application before national and regional patent offices. If no international preliminary
examination has been requested, the International Bureau establishes an international preliminary report
on patentability (IPRP Chapter I) on the basis of the written opinion of the ISA and communicates this
report to the designated offices.
The procedure under the PCT has numerous advantages for applicants, patent offices and the general
public:
(i) applicants have up to 18 months more than if they had not used the PCT to reflect on the desirability of
seeking protection in foreign countries, appoint local patent agents in each foreign country, prepare the
necessary translations and pay national fees;
(ii) applicants can rest assured that, if their international application meets the PCT formality requirements,
it cannot be rejected on formal grounds by any designated office during the national phase;
(iii) on the basis of the international search report and the written opinion, applicants can assess the chances
of their invention meeting the patentability requirements;
(iv) applicants have the possibility, during the optional international preliminary examination procedure,
to amend the international application and thus put it in order before processing by the various national
and regional patent offices;
(v) the search and examination work of patent offices in the national phase can be reduced thanks to the
international search report and the written opinion which are communicated to national Offices together
with the international application;
(vi) applicants are able to access fast-track examination procedures in the national phase in Contracting
States that have PCT-Patent Prosecution Highway (PCT-PPH) agreements or similar arrangements;
(vii) since each international application is published with an international search report, third parties are
in a better position to formulate a well-founded opinion about the potential patentability of the claimed
invention; and
(viii) for applicants, international publication on PATENTSCOPE puts the world on notice of their
applications, which can be an effective means of advertising and looking for potential licensees.
Ultimately, the PCT:
• brings the world within reach;
• streamlines the process of fulfilling diverse formality requirements;
• postpones the major costs associated with international patent protection;
• provides a strong basis for patenting decisions; and
• is used by the world's major corporations, research institutions and universities in seeking
international patent protection.
The PCT created a Union which has an Assembly. Every State party to the PCT is a member of the
Assembly. Among the most important tasks of the Assembly are the amendment of the Regulations issued
under the Treaty, the adoption of the biennial program and budget of the Union and the fixing of certain
fees connected with the use of the PCT system.
The PCT offers a reduction of one of the fees to be paid at the time of filing (the international filing fee)
by 90% to applicants from certain States. Applicants from one group of States (which meet specific criteria
on gross domestic product and numbers of PCT applications filed) must be natural persons who are
nationals and residents of the qualifying State. And for a second group of States (classified by the United
Nations as least developed countries), applicants can be either natural persons or legal entities. The lists of
the States qualifying for these reductions are updated every five years.
CONVENTIONAL DIVISIONAL AND PATENT OF ADDITION
Provisional Patent Application
A provisional application is an interim patent application which is filed with a provisional specification. It
is an optional application and need not be filed by every applicant. Every provisional application must be
followed by a complete patent application in order to proceed for consideration by the IPO.
A provisional specification is expected to sufficiently cover the subject matter of the invention but need
not contain all the sections or portions required in a regular patent application. It is usually filed when the
invention has been developed, but experimental data or additional information to support the disclosure is
still being collected. A provisional application helps establish a priority date for the invention and show
that the applicant adequately possessed the invention at the date of filing of the application. It also gives
the applicant sufficient time to evaluate the market potential of the disclosed invention before filing a
complete specification. A provisional application need not include claims, and such applications are neither
published nor examined.
A single provisional application can be the basis for filing more than one complete application so long as
the provisional application includes support for each of those complete applications.
A complete patent application must be filed within 12 months of filing its corresponding provisional
application. This timeline is not extendable under any circumstances. If an applicant does not file a non-
provisional or complete application within 12 months, the provisional application is deemed to have been
abandoned.
Complete Patent Application
A complete application is an application filed along with a complete specification describing the invention
fully and particularly, including the best mode of working the invention. It can be filed directly or within
12 months of filing the provisional patent application. Complete patent applications can be of various
kinds, depending on the priority sought, or the nature of the invention, as follows:
Depending on priority:
• Convention patent application
• PCT patent application
• National Phase patent application
Depending on invention:
• Divisional patent application
• Application for a patent of addition
Convention Patent Application
A convention application is an application that claims a priority date based on the same or substantially
similar applications filed in one or more “convention countries”, i.e., parties to the Paris Convention for
the Protection of Industrial Property. It must be filed within 12 months from the date of the first filing of a
similar application in the convention country. For example, if an application for a patent is filed in the
United States (“US”), a corresponding Indian convention application must be filed within 12 months of
filing in the US.
The total number of applications filed in India claiming priority under the Paris Convention during the year
2018-2019 was 3,911 which was an 8% increase on the previous year figure of 3,644.
PCT patent application
A PCT application is an application filed under the Patent Cooperation Treaty (“PCT”). It is first filed at
one of the receiving offices under the treaty. The applicant may then file a “National Phase” application
corresponding to the parent PCT application in any of the member states of the treaty within the prescribed
time.
A PCT patent application effectively allows the applicant to postpone the expense of filing individual
national patent applications in each of the countries where protection is sought. This also provides the
applicant time to assess the value of the invention and analyse potential markets before making more
significant investments in securing patent rights in multiple jurisdictions.
India is a member of the PCT. For a full list of the PCT members, please refer
to [Link] PCT applications may be filed first in India, in
relation to which National Phase patent applications may be filed in other member countries.
National Phase patent application
A National Phase application arises out of a PCT application. Such applications can be filed regardless of
whether the parent PCT application has been published. A National Phase application in India must be filed
within 31 months of the filing or priority date of the PCT application, whichever is earlier. This timeline is
not extendable.
Most foreign applications in India are filed through the PCT National Phase route. The number of such
applications filed in 2018-2019 was 26,966, which is a modest increase from the previous year’s figure of
26,584.
Divisional patent application
If the claims of a patent application relate to more than one invention, then the applicant may file a
divisional application either suo moto or in response to an objection raised on the ground of plurality of
distinct inventions in the claims by the IPO.
A divisional application can be filed any time before the grant of the parent application.
Applicants must be cautious that a patent may be granted or refused at any time after filing a response to
the First Examination Report, Thus, if an applicant intends to file a divisional application, it should be filed
as soon as possible. If a divisional application is voluntarily filed, during examination, the Examiner will
assess whether or not the parent application relates to plurality of inventions.
The term of patent for a divisional application is the same as the term of the parent application, i.e., 20
years from the filing date or priority date of the parent application. Such applications are treated as
substantive applications, and all the fees applicable to regular applications are payable in case of divisional
applications as well.
Application for a patent of addition
An application for a patent of addition is made for an improvement or modification of an earlier invention
for which the applicant has already applied for or has obtained a patent. It is granted only after the grant of
the parent patent. However, if the parent patent is revoked, the patent of addition may be converted into an
independent patent, upon the applicant’s request.
An application for a patent of addition can be filed at any time after the filing of the parent application. It
can even be filed after the grant of the parent patent and no separate renewal fee is required to be paid for
a patent of addition. A patent of addition expires along with the parent application.
The examination of a patent of addition can only consider the main invention described in the complete
specification of the parent patent or parent patent application for the purposes of assessing novelty but not
for assessing the inventive step of a patent of addition.
FORMS AND FEES INVENTION IN CONTEXT OF PRIOR ART
◼ Prior art refers to scientific and technical information that exists prior to the
effective date of a patent application
 Characteristics of Prior Art Information

◼ Information include all published scientific and technical information

◼ Rich in information of cutting-edge technologies
◼ Concrete description and specific technological
information
◼ Presentation and data elements based on WIPO standards (uniformed
structure)
◼ Can be freely used to support research
◼ Problem solving approach

Characteristics of Prior Art Information

◼ Potential economic value

◼ Renders exclusive rights
◼ Industry oriented information
◼ Identifies competition in early stage
◼ Information on legal status of patent applications
◼ Essential tool for successful IP protection, licensing and commercialization
◼ Over 60 million documents made available on Internet
Main Purposes of Prior Art Search

◼ To generate ideas for R&D

◼ To avoid duplicate of research
◼ To reduce significantly R&D investment
◼ To develop new technical solutions to problems
◼ To evaluate specific technology
◼ To plan new products
◼ To identify state-of-art of technology
◼ To find legal status of patent applications
◼ To assess novelty and patentability
◼ To market for commercialization
◼ To update new technological trends
◼ To monitor competitor’s research activities
◼ To prevent infringement actions (validity, ownership etc.)

DifferentDifferent
Different Purposes of Prior Art Search

Technological
Purposes
Purposes ofof PriorPrior
◼

• Focus of Research area to avoid redundant research

• Novelty

ArtArt • State-of-the-art searches

• Decision of Patent Application (patentability searches)
• Patent examination searches

◼ Legal
• validity searches
• Legal status of patent application
• e.g., Detection of possible infringement,

◼ Economic
• R&D investment strategy (e.g., Preventing overlap of investment)
• IP as economic asset
• Marketing
• Commercialization
• Competitors activities
 Users of Prior Art

◼ IPOs
◼ Scientific researchers
◼ University/ R&D Institution managers
◼ Potential inventors and applicants TMO
◼ Companies
◼ IP practitioners (IP lawyers, patent agents)

Significance of Prior Art searches in the Process of Patent Prosecution

◼ May speed patent prosecution by allowing claims to be tailored to avoid the

prior art before the examiner’s own search
• Know early on without investing much time, effort and money if an
application is patentable
• May sometimes assist in determining how to allocate R&D funds if
want to investigate a relatively unexplored area

◼ May help avoid being patent infringer

• But a different kind of analysis is required
PATENT DATABASES / SEARCHING INTERNATIONAL DATABASES / COUNTRY
WISE PATENT SEARCH
One of the most crucial steps in the process of securing patent rights is the patent search. The
process for undertaking a patent search has changed extensively over time. Before the age of
computers, individuals seeking to search a patent history were forced to look through
microfiche and hard copies of filed patents. The process was long and painstaking.

Computers dramatically changed the manner in which we research prior patent filings. Now
patent applications are generally stored in both private and public databases. Searching for prior
patents now happens almost entirely electronically. The companies or governments that
manage the patent databases develop search algorithms to more effectively search.

In this article we mention the most-commonly searched patent databases. We explain the
advantages of each database and the basic process for performing a search in them.
Google Patent Search Database
Google has created the most well-known, free database available through a private company.
The database contains patent filings compiled from the major patent offices all over the world.

Google Patents is very user friendly and fast. The interface is developed for the novice in mind,
but there is also an advanced patent search function for more seasoned patent searchers. The
search function is extremely strong. The search engine produce results of search in less than a
second. Also, the search generally provides a history of legal actions concerning the patent
application. This includes any back-and-forth between the patent examiner and the inventor.
Lastly, the format for viewing the results is very pleasing.

As stated above, Google patent offers a “simple search” feature and an “advanced search”
feature.

The simple search functions allows for keyword searches for relevant technology. It also allows
for direct search of publication numbers. While it does not require them, the simple search
allows for the use of boolean operators in your keyword searches. This is very helpful when
combining keywords for broad search. Further, the search can be narrowed by searches in the
claims, title, abstract sections or within relevant classification codes.

The advanced search function provides numerous additional search criteria that is not provided
in the simple search, such as: inventor, assignee of patent rights, patent office, language, filing
status, patent type, citing patent. It allows for identification of keywords in the description of
the patent publication. The major patent offices queried for patent information are the United
States, Europe, Japan, China, South Korea, WIPO, Russia, Germany, The United Kingdom,
Canada, France, Spain, Belgium, Denmark, Finland, Luxembourg, and The Netherlands.

One of the few negatives of Google’s patent database it hat is does not offer a multi-word search
function. Also, the Google database is not always as up-to-date on recent patent filings as paid
search databases.
Patentscope
Patentscope is a free database put out by the World Intellectual Property Organization (WIPO).
Patentscope is a very comprehensive database. It contains patent applications from all major
patent-filing countries and international patent applications filed under the PCT (Patent
Cooperation Treaty). The search interface is available in 9 languages. There is a mobile
interface for searches on smart devices.

There are 4 primary search methods:

You can use the SIMPLE SEARCH interface to search for:

• Filing Number: a reference to patent document in the press, in a trial, etc.

• Inventor
• Company
• IPC Code
• Date of Filing
• Technology field
• Descriptive Keywords

There are 8 predefined search fields available, each defining different search criteria:

• FRONT PAGE: the search criteria you entered in this field will be searched in the front page
of the document.
• ANY FIELD: the search criteria you entered in this field will be searched in any fields of the
document.
• FULL-TEXT: enter your query in this field if you are interested in full-text.
• ENGLISH TEXT: the search criteria you entered in this field will be searched in texts in
English.
• ID/NUMBER: enter publication number, filing number, etc.
• IPC: enter any International Patent Classification code.
• NAMES: enter your search in this field to look for the name of an inventor, an applicant, a
company, etc.
• DATES: enter any date in this field such as filing date, publication date, etc.

The ADVANCED SEARCH in PATENTSCOPE is far more complex. It allows expert

searchers to create complex search queries using an unlimited number of terms. Boolean,
proximity, and range operators are used to combine search terms. Also the interface allows the
use of field codes to define the fields in which search terms must be found. The FIELD
COMBINATION SEARCH is a list of preset search fields that can be combined for a more
targeted search.

CLIR stands for Cross Lingual Information Retrieval and will allow you to search for keywords
in the following languages:

• Chinese
• Dutch
• English
• French
• German
• Italian
• Japanese
• Korean
• Portuguese
• Russian
• Spanish and
• Swedish

PatentScope also allow you to browse recently filed applications. You can browse by week
filed and by sequence listing. There is also a function that allows you to verify the legal status
of the patent.
The USPTO Database
The United States Patent and Trademark Office (USPTO) is charged with granting patent rights
within the United States. They provide a number of resources to facilitate this process. The
primary database features are as follows:

PatFT - The PatFT database offers full texts of patents filed after 1976. For patent applications
filed prior to 1976, the PatFT database will provide the patent applications in PDF image
format.

AppFT - The AppFT database provides full texts and images of patents applications filed. This
includes applications that are not successfully prosecuted to completion.

PAIR - The Patent Application and Retrieval (PAIR) database provides information about
patent applications that are currently pending before the USPTO. It will also include aspects of
the legal history between the inventor and the USPTO.

Collectively, each of these database functions facilitate a quick search with keywords within
any of the fields or search criteria. You can focus the search by class or sub-class, pursuant to
the Cooperative Patent Classification (CPC) system.
Espace European Database
Last, but not least, among the commonly-recognized, free databases is Espace. Espace is
perhaps the best source for searching European and international patent applications. It allows
for search of patent publications, machine translate patent documents (Chinese, Japanese, and
Korean to English), track emerging technologies, and identify what competitors are
developing.

Espace also provides a powerful classification search tool. This will help in the process of
retrieving publications from a particular technical area. Espace provides a “Global Dossier”,
which brings together documents when the same documents have been filed in multiple patent
offices around the world. It provides access to the correspondence (“File Wrapper”) between
applicants/attorneys and the offices of filing (Canda, China, Europe, Korea, Japan, US, PCT
applications, etc).

Lastly, Espace has a common citation document (CCD) tool that provides a single point of
acres to citation data for the patent applications in the largest five IP offices. Basically, it
consolidates the prior art cited by the participating offices and shows those search results on a
single page.
Paid Databases
There are a number of paid databases that provide the same services available in Google,
Espace, and PatentScope. These databases are generally more suitable to patent search
professionals. They offer all sorts of search functions that are not available in the free databases.
The downside is that accessing these databases is exceptionally expensive. Most of these
databases are on subscriptions purchased by patent professionals. The most well-known paid
databases are Pat base, Orbit, and Derwent.
NATIONAL AND PCT FILLING PROCEDURE
The Patent Cooperation Treaty (PCT) is an agreement strengthening international cooperation
towards harmonization of patenting at the international level. Major objective of the PCT is to
ease the method of patenting thus making it more efficient, effective and economical within
the interests of applicants seeking patents in several countries. The treaty makes it possible to
get patent protection for an invention simultaneously in a number of nations by filing an
`International Patent Application’. Such an application is filed by anyone who could be a
national or resident of a contracting country party to the PCT. The treaty enables the filing,
with one Patent Office, of one application in a single language having effect in each of the
contracting countries, which the applicant `designates’ in his/her application. The PCT
becomes relevant only if the applicant is keen on filing an application in several countries. If
he/she is interested on filing a patent in one country only, the PCT has no relevance.
The PCT provides a framework for circulation of technical information among the Contracting
countries. It promotes the exchange of technical information contained in a very patent
document among the countries signatory to the treaty and also with the scientific community
concerned with the particular invention.
The treaty only simplifies the procedure for an applicant to get patents for his/her invention in
a number of states designated for the same. Although the PCT application is termed as an
`international application’ the treaty doesn't provide for the `international patent’ which is left
to the particular country within which the patent is sought by the applicant. The PCT isn't a
platform for grant of patents. Patents still are granted by various National Patent Offices
(referred to as `Designated Offices’) within which patent protection is sought by designating
the application in that particular country.
The article aims to discuss the functionality of the Patent Cooperation Treaty with a view of
analyzing the recent developments in PCT System. The article shall also focus on elucidating
the procedure of filing PCT Applications (both international and national phase) for India.
PCT SYSTEM : TRACING THE RECENT DEVELOPMENTS
Recently, a number of changes have been made to enhance the functionality of the PCT system.
The changes are enlisted as:
a) PATENTSCOPE
PATENTSCOPE gives a user free access to over 67 million patent documents additionally to
over 3.3 million PCT applications. It consists of the national patent data collections of several
Patent Offices. PATENTSCOPE features a varied number of powerful tools, including cross-
lingual and compound search in addition to artificial intelligence.

Interface is now available in 10 languages. The 'Documents' tab consists of the new section
termed as 'Search and Examination-Related Documents'. A brand new secure access system
associated with PATENTSCOPE is running via https. Moreover, Cross-Lingual Information
Retrieval (CLIR) (Cross-Lingual Expansion) has been developed allowing the search of a
term/phrase and its variants in several languages. By entering the key term in one language,
the system will suggest you all possible variants and can then translate the term(s), also
facilitating the search of patent documents in other languages.
b) WIPO Pearl
A new feature called "WIPO Pearl" has now been added to the WIPO database which is a web
terminology database used for searching multilingual contents. This is available in altogether
10 PCT languages. It helps to market accurate use of key terms across various languages and
also makes it easier to look and share scientific and technical knowledge. All the content under
"WIPO Pearl" is validated by WIPO language experts and experienced terminologists.
c) Licensing availability
Applicants whoever are keen on executing licensing agreements in respect to their PCT
application can intimate the International Bureau (IB) and request them to furnish the required
information on PATENTSCOPE. Applicants should submit a "Licensing Availability Request"
and fill form PCT/IB/382 and submit it to the IB using an ePCT "Action". It should be noted
that this request is made at the time of filing or within 30 months from the priority date.
Applicants can file multiple licensing requests or update previously submitted ones (within 30
months from the priority date). The licensing indications are going to be then appeared on
PATENTSCOPE under the "Bibliographic data" tab together with a link to the submitted
licensing request.
WIPO GREEN, which has been revised now, is additionally a related platform that matches
owners of environmentally sound technologies (ESTs) with technologies that are seeking
licensing or partnership agreements.
d) Third Party Observations
Under this feature, third parties get an opportunity to submit their respective prior art
observations relevant to 'novelty' and 'inventive step'. It’s a Web-based system which uses ePCT
or web-forms in PATENTSCOPE. Submissions are possible until the expiration date, which is
28 months from the priority date. Applicants may submit their comments in response to those
observations until the expiration of 30 months from the priority date. This technique makes
observations available in PATENTSCOPE and it notifies the applicant of submission of
observations.
e) PCT Direct
New services are being offered by the EPO and Israel Patent and Trademark Office Database
within which applicants can address their issues regarding patentability in search opinion
established for the priority application by the office itself. Its aim is to enhance the efficiency
and quality of the procedure adopted by ISA. The informal comments are filed along with the
application termed "PCT Direct Letter".
f) Fee Reductions in WIPO Arbitration and Mediation Center (AMC)
25% lifetime reduction is obtainable on AMC's registration and administration fees, wherein a
minimum of one party to the dispute has been named as an applicant or inventor in a very
published PCT application (no relationship to the dispute is required).
AMC is an independent body that gives alternative resolution options for commercial disputes
between private parties. It gives time and value efficient alternatives to litigation.

g) Time-limit for Supplementary search request

The deadline for requesting supplementary international search has been extended from 19
months to 22 months from the priority date (PCT Rule 45bis.1).
h) 90% fee reductions
An amendment was made to the PCT Schedule of Fees which clarifies an understanding that
the 90% fee reductions in item 5 of the Schedule of Fees are intended just for persons filing a
global application in their claim and not those filing a global application on behalf of an
individual or entity which isn't eligible for the reduction.
INTERNATIONAL PATENT FILING VIA PCT
PCT provides a platform for applicants seeking patent protection for his or her inventions
internationally. By one international application under PCT filing, applicants can
simultaneously obtain protection for his or her invention in an exceeding number of nations.
Currently, PCT has 153 Contracting States.
PCT being a world regime to safeguard inventions by granting patents, it does consist of some
rules and procedure of its own for doing so. Among them some are mandatory (such as filing
of the patent application, international search, international publication and national phase) and
a few are optional (such as supplementary international search and international preliminary
examination). When the applicant files the PCT application at the regional authority or directly
at international authority, the same is examined by the ISA (International Search Authority)
whether its patentable or not and published in international journals in order to make the whole
world comprehend the invention making a room for the oppositions to be filed globally.
Though the examination and publication are done by international authority, the granting of
patents remains under the control of the national or regional Patent Offices in the stage termed
as "national phase".
General Procedure for Filing an application under PCT
The procedure for filing a patent application under PCT consists of a couple of phases. It starts
with the filing of a global application (international phase) and ends with the grant of variety
of national and/or regional patents (national phase). The international phase consists of the
subsequent stages.
• Filing of the international application by an applicant and its processing by the
“Receiving Office”.
• Generation of the International Search Report (ISR) and written opinion by
International Searching Authorities (ISA).
• Publication of the international application with ISR and written opinion by IB of
WIPO.
• Conducting a supplementary international search by one or more of the International
Searching Authorities (authority apart from the one that conducted the major
international search) and generation of Supplementary International Search Report
(SISR). (Optional)
• The international preliminary examination concludes with the establishment of the
International Preliminary Report on Patentability (IPRP) by one among the
International Preliminary Examining Authorities. (Optional)
• Communication of published international application, ISR, and other reports
(optional) to the national and/or regional Offices (designated states) by the IB where
the applicant wishes to receive patent protection.
Based on published international application, the applicant proceeds with the formalities of the
national phase like patent national and/or regional fees, translated copy of the international
application (if required), patent agent or representative where required, within a given time-
frame or limit. Thereafter, national and/or regional offices examine the same, and grant or
refuse the national and/or regional application subject to their national laws.
Costs related to an Application
PCT applicants generally pay three forms of fees once they file their international applications:
• an international filing fee,
• a search fee which might vary reckoning on the ISA chosen, and
• a small transmittal fee which varies looking on the receiving Office.
Cost of Filing a PCT Application for India
• Transmittal fee of e-filing- Natural Person- 3200 INR, Small Entity – 8000 INR, Others
– 16000 INR and for physical filing – Natural Person- 3250 INR, Small Entity – 8800
INR, Others – 17600 INR
 • International filing fee for Indian Applicant – 1471 USD (Fee per sheet over 30 is 17
USD and reduction in fee for PCT easy filing 11 USD)
• Search fee for Indian applicant choosing Indian Patent Office as ISA, for individuals
2500 INR and others 10,000 INR.
• Preliminary Examination fee where the ISR was issued by ISA/IN for persons is 2500
INR and others 10,000 INR and where the ISR wasn't issued by ISA/IN for individuals
is 3000 INR and others 12,000 INR.
NATIONAL PHASE PCT APPLICATION
Within 31 months from the priority date, the patent application enters the National Phase PCT
application. The National Phase of a PCT application resembles a national filing within a
respective country. The choice to grant patent protection in a very nation finally rests on the
Patent Office of that particular country. However, the filing of a PCT application is far simpler
than the filing of a normal national application since most of the formal requirements are
resolved within the international phase itself. Also, the national examiners most frequently
follow the Search Report conducted during the International Phase.
Documents to be Furnished
• Furnishing of a translation (in English). Required contents of Translation are:
Description, claims (if amended, both as originally filed and as amended, along with
any statement under PCT Article 19), any text matter of drawings, abstract.
• A copy of the international application is required given that the applicant has not
received Form PCT/IB/308 and also the Patent Office hasn’t received a duplicate of the
international application from the International Bureau under PCT Article 20.
Miscellaneous Documents Required
• Name, address and nationality of the inventor if they were not furnished within the
"Request" section of the international application.
• Instrument of assignment or transfer where the applicant is really not the inventor
• Document evidencing a change of name of the applicant if the change occurred after
the international filing date and has not been reflected in a very notification from the
International Bureau (Form PCT/IB/306)
• Declaration of inventorship by the applicant
• Address for service in India (but no representation by an agent is required)
• Power of attorney if an agent is appointed
• Verification of translation: Verification does consist of a straightforward statement by
the Applicant or his agent that the said translation is correct and complete.
• International application or translation to be furnished in two copies
• Furnishing, where applicable, of a nucleotide and/or organic compound sequence
listing in electronic form;
In case there are corresponding applications in other countries, the applicant must file within
six months from the date of entry into the national phase, an announcement concerning any
corresponding applications filed in other countries. The statement must be made on Form 3.
The application needs to be filed at any of the four Patent Offices located at Delhi, Kolkata,
Chennai or Mumbai, reckoning on the domicile, business or place of the Applicant. If the
applicant for the patent has no business, place or domicile in India, the suitable Patent Office
is going to be the address of service in India.
Procedure : National Phase PCT Application in India
• Publication: Every application is published after 18 months from the date of filing.
Thus, letter of invitation for earlier publication is made in Form 9 together with the
prescribed fee. Once published, the patent application is deemed to be available to the
general public domain.
• Request for Examination: An Applicant should file Request For Examination (RFE)
within 48 months from filing. The Controller forwards the documents to the Examiner
within a month from the date of publication or one month from RFE, whichever is later.
Within a period of three months from the time of receiving the documents from the
Controller, the Examiner establishes the examination report. The Controller forwards
the Report (also referred to as First Examination Report, FER) to the applicant or his
agent within 6 months from the date of publication or from the date of RFE, whichever
is later. An applicant has got to conform to the requirements imposed on him within a
period of 12 months from the date on which the FER is forwarded to him, else the patent
application is deemed as abandoned.
• Grant of Patent: After the instructions/ objections of the Controller are complied with,
the patent application together with the whole specification is published in Patent
Journal. The said application is receptive of oppositions for a period of 4 months or for
such further period as prescribed. If no oppositions are filed or if the opposition has
successfully been overcame, the application will proceed for grant of the patent.
Fees
The official fee for filing a PCT Application (Patent Cooperation Treaty) and request for
examination would be minimum US$470 for an outsized entity and US$94 for a smaller entity,
and it varies depending upon the quantity of pages and claims.
PCT FILING IN INDIA: AN OVERVIEW
PCT is normally filed with the National Patent Office of the Contracting State of which the
applicant could be a citizen or resident or, at the applicant’s option, with the International
Bureau of WIPO in Geneva. If the applicant comes up as a national or resident of a Contracting
State party to the EU Patent Convention, the Harare Protocol on Patents and Industrial Designs
(Harare Protocol), the Bangui Agreement, or the Eurasian Patent Convention, the international
application may additionally be filed with the EU Patent Office (EPO), the African Regional
IP Organization (ARIPO), the African IP Organization (OAPI) or the Eurasian Patent Office
(EAPO), respectively.
PCT provides a platform for applicants seeking patent protection for his or her inventions
internationally. By filing one international application under PCT, applicants can
simultaneously obtain protection for his or her invention in huge number of nations.
Procedure to file PCT application (PCT Filing)
In 1998 India became a signatory to Patent Cooperation Treaty. The patent cooperation treaty
provides an individual exact thirty months time from the date of the first filing to file the
application. Additionally it provides International search reports. This report will guide one
regarding filing of an application further in other countries.
One can file PCT application either with a regional office like Indian Patent Office or with the
International Bureau- World Intellectual Property Right organization office in Geneva,
Switzerland. PCT application must be filed within twelve months from the date of Regional/
Indian patent filing date by claiming priority. Now if one directly wants to file an application
via Patent Cooperation treaty and not in regional office, for that one simply needs to take
permission from the Indian authority.
Usually, one can file a PCT application (PCT Filing) with the International Bureau because it's
highly economical. International application fees, International searching authority fees and
priority fees are involved with stages. Priority fees is only applicable just in case one has filed
the patent application in regional office. After filing PCT application, the said application shall
be examined within nine months only if one has got the PCT application directly with the
International Bureau or sixteen months if he or she has filed PCT application with claiming
priority. International Preliminary Examination concludes with the establishment of the
International Preliminary Report on Patentability (IPRP) by one among the International
Preliminary Examining Authorities. (Optional) Communication of published international
application, ISR, and other reports (optional) to the national and/or regional Offices (designated
states) by the IB where the applicant wishes to receive patent protection.
A Few Important Initiatives taken by the Indian Patent Office (IPO) to facilitate PCT Filings
IPO as DAS
The Indian Patent Office (IPO) commenced operating as both, a Depositing and an Accessing
office of DAS with effect from 31 January 2018. If the applicant has requested as a depositing
Office, it shall submit certified copies of patent applications and style applications as priority
documents in DAS, including PCT applications filed at the Office on or after 31 January 2018.
As an Accessing Office, it shall recognize all the relevant priority documents available thereto
through DAS platform for the needs of any application that the deadline for submitting the
priority document has not expired by 31 January 2018. Priority documents will be transmitted
to IB through WIPODAS.
Currency issue resolved
A new INR A/C has been opened under the name of CGPDTM at the Central Bank of India
FOREX division and therefore the USD A/C in SBI Overseas bank has been closed now. The
applicant can make payments directly through NEFT /RTGS towards IB fee and ISA and
submit the UTR /Ref numbers via email to RO/IN. RO will prepare debit instructions to the
bank and transmit the payment subsequently to IB and ISA. It shall also intimate the said
through e-mail to any or all International authorities. Transmittal and Priority fee also can be
paid through form 30 via the net payment portal.

CONCLUSION
There are certain ways to file a patent application within a country of interest. The selection is
typically subject to a business strategy, and balanced by cost considerations. If protection of
the invention is required in a handful of countries, it's usually most economical to file directly
into those countries and claim priority to any provisional application which has been filed –
called (Paris) Convention applications. Alternatively, where an applicant requires a large
number of countries, it's more common to file a Patent Cooperation Treaty (PCT) application
(and claim priority). However, it is indeed possible to pursue Convention applications in
parallel with a PCT application.
The strategy of filing Convention applications incurs relatively-expensive filing costs sooner
compared to filing a PCT application, where the key filing costs are deferred for 18 months –
a period named the International Phase. In other words, the PCT application takes the place of
the individual foreign patent applications that will otherwise be required. After the International
Phase, during a period named as National/Regional Phase, the PCT application is converted
into individual foreign patent applications, one in each country where patent protection is to be
sought.
The decision of whether to file Convention applications or a PCT application (and subsequently
enter the national/regional phase) depends on the budget and therefore the commercial strategy.
Assuming a PCT application is filed, there's an additional decision on whether to file a
requirement, which depends on factors like the commercial stage of the merchandise, the
interest of licensees, the scope of the planned national/regional filings, the budget, and also the
scope of the prior art cited in ISR.
STATUS OF PATENT APPLICATION FILED
Status of a Patent Application
Introduction:
Following the submission of a patent application, the option to check the status of the
application is at the applicant’s disposal. It is advised that the application be closely monitored
to ensure that updates or deadlines are not missed and additional requirements, if any, can be
met. Understanding the various application statuses can assist the applicant in taking the
appropriate action in accordance with the corresponding status.
Types of Statuses of a Patent Application:
1. Application Does Not Exist/ Not Yet Published: Generally, a patent application is
published by the Indian Patent Office (IPO), 18 months following the patent’s filing
date or priority date, whichever is earlier. This is the status that can be anticipated if 18
months have not passed since the priority date or date the patent application was filed.
• Application Published: After 18 months from the priority date or application filing date,
whichever is earlier, only the applications which are complete are published. This
 status indicates that the patent application has been published in the official gazette and
has been made available for public scrutiny by the IPO.
• Application Awaiting Examination: When an application is in this stage, it signifies that
the applicant has submitted a request for examination and the application is awaiting
the examiner’s assessment. Such a request must be filed within 48 months from the date
of priority or date of filing, whichever is earlier. Failure to comply with the same shall
result in the application being considered as withdrawn.
• Application Examined [First Examination Report (FER) Issued]: This status implies
that the application has been assessed and the First Examination Report has been issued
by the Controller. The response to the FER must be submitted within 6 months from
the date of FER. The response time is extendable by 3 months.
• Application in Amended Stage: If any amendments are file in response to the FER, the
application will be displayed as being in this stage. These amendments must be
submitted with 6 months from the date of FER. A 3-month extension is available,
however, if the response is still not filed, the application is deemed to be abandoned.
• Abandoned: The application is discontinued and cannot be resurrected once it gets
abandoned. This abandonment occurs at two instances:
• Section 9: Failure to file a complete specification with 12 months following the date of
filing for provisional specification shall result in the application being abandoned.
• Section 21(1): If the application for the grant of patent is not put in order within 6
months from the date on which the FER was issued, the application gets abandoned.
• Withdrawn: An application stands withdrawn on two occasions:
• Rule 26: When a voluntary request for withdrawal is made by the applicant pursuant to
sub-section (4) of Section 11B in Form 29. Such request shall be made within 48
months from the date of priority or filing, whichever is earlier. This legally permitted
time frame is not subject to any exemption or extension. The applicant can request for
a 90% refund of the examination fees, from the Patent Office before the FER is issued.
• Section 11B (4): When the Request for Examination (RFE) is not provided within 48
months following the date of filing or priority, whichever is earlier.
• Application Refused: The application stand refused under Section 15 once the
Controller is satisfied that it does not adhere to the standards of The Indian Patent Act,
1970.
• Granted: This status indicates that all objections to the application have been
surmounted. Consequently, the patent is granted and published in the official Patent
Gazette. After the grant, the patent holder is obligated to renew their patent from the
3rd year onward by paying an annual renewal fee. In India, a patent may be renewed
for 20 years from the date of first filing.
Conclusion:
It can be disastrous to miss the deadlines of a patent application. Once a deadline is missed, no
statutory remedy can revive the application. Therefore, it is imperative for an applicant to
comprehend and be cognizant of the current status of their application. They must exercise
greater caution to retain legal rights over their priceless inventions and be vigilant of the
application timelines.
PRECAUTIONS WHILE PATENTING
A patent is a form of Intellectual Property, which provide exclusive rights to the patent holder
to protect scientific and technological inventions. Simply put, a patent is an exclusive right
conferred by the Government on an inventor, to prevent others from exploiting the patent
without his permission. Therefore, it is beneficial to file a patent application to get an exclusive
of the invention. Let us go through the following do’s and don’ts for the consideration before
and after filing for patent applications.

Do’s before filing a patent application

It is advisable to file a patent for a single invention or multiple inventions having ‘unity of
invention ‘. For an invention to be patentable, it needs to fulfil three essential criteria. First, the
novelty of the invention that is the invention must be new. Second, it should involve an
inventive step and be non-obvious wherein the technical value added to the product. Third, it
should have a use or any application in the industry (Industrial Application). If the invention
satisfies the above these three requirements, the inventor can apply for a grant of a patent.
However, the invention should not fall under subjects that are non-patentable such as laws of
nature, traditional knowledge, inventions related to atomic energy, etc.
Before filling the patent, the applicant may also conduct a patentability search to ensure that
similar inventions do not exist that would hamper the application process. The true and first
inventor, his assignee, or their legal representative can file a patent application for the
invention. The inventor must also file for the right kind of patent and the right type of protection
to fully utilize the protection offered.
Further, before filing a patent application, it is advisable to determine whether one wants to
submit a provisional patent application or a non-provisional patent application [NPA] either
online or manually. The inventor must also decide where he would want to file for the patent
as patent laws may vary across various jurisdictions. The inventor can submit the patent
application at the earliest possible date as India has a “first to file” system. Under this system,
the first person who applies gets a grant of the patent.
Don’ts before filing a patent application
It is also imperative that the inventor neither publishes nor discloses his invention in
newspapers or scientific journals before applying the patent application. The publication could
constitute prior art, thereby acting as an obstacle for a patent even if the inventor did the
publication. It is necessary that all the steps and examples of the invention are accurately
recorded and mentioned in the patent specification to ensure that it enables the public to
reproduce the invented product or process.
An inventor must also be careful not to use their inventions for fundraising as may be required
by many startups. It is advisable to disclose only after applying for a patent as it can otherwise
result in misuse. Further, even filing for a provisional application would ensure that there is no
infringement from competitors, and if there were, the invention would not warrant protection.
It would be beneficial that the inventor does not wait for the invention to fully completed and
then file an application. This provisional application is favourable for the invention that is not
fully developed, and for providing a complete specification that is not practically possible. A
provisional specification is required to give only the critical novelty and inventive aspect of the
invention without claims. However, the inventor must also ensure that no infringement of a
third party right. Further, the inventor must even not bank on copyright protection, as the
copyright protection would not protect an invention.
Do’s after filing a patent application
Depending upon the type of application filed, the applicant needs to fulfil further process
requirements that may vary. In case of a provisional application, ensure to submit a complete
specification within 12 months from the date of provisional filing; otherwise, the patent
application would lapse. After applying for the grant of a patent, the applicant can mention
“patent-pending,” wherever using that invention. In case multiple provisional specifications
were filed for associated inventions, the same can be combined to form a single complete
specification.
Once submitting the patent application, in general, the publication of complete patent
specification happens after 18 months. Otherwise, a request for early publication needs to send
to the patent office to get before publication. The applicants should note that the examination
of the application has to be requested and would not be undertaken automatically, like the
publication. The applicant may even ask for a fast-track examination along with the prescribed
fee.
Don’ts after filing a patent application
Once the first examination report [FER] is sent to the patent applicant and also uploaded online
for the general public, the applicant must acknowledge and respond to the FER, and any other
examination reports post that. An applicant may also convert a complete specification into
provisional specification within twelve months from the filing of the complete specification
provided that it is not a convention application or a PCT national phase application.
When filing the complete specification, one should carefully ensure the scope of the patent
claims fall within the specification drafted and to cover all the aspects of the protection sought,
while simultaneously distinguishing the prior art from the claimed invention. The applicant
must keep in mind that the claims are not too broad to embrace more than what the applicant
has invented to ensure that the claims do not infringe upon information or matter that already
exists in the public domain. However, it must also not be too narrow either, as it would reduce
the scope of protection.
FINANCIAL ASSISTANCE FOR PATENTING
Scheme Details
1. Intellectual Property Rights Support Scheme: With the objective of spreading
awareness and providing assistance for IPR (Intellectual Property Rights), this scheme
aims to offer financial assistance of up to INR 2 Lakhs for a domestic patent
application and up to INR 10 Lakhs for an international patent application, subject
to 80% contribution by MSInS, on a reimbursement basis.
Under this scheme, DPIIT-recognized startups incorporated in Maharashtra, with a revenue of
less than Rs. 1 crore and funding of less than INR 3 crores shall be eligible for domestic patent
support. DPIIT-registered startups incorporated in Maharashtra, with a revenue of less than
INR 5 crores and funding of less than INR 3 crores shall be eligible for international patent
support.
In case the startup has raised funds of more than INR 3 crores, MSInS shall support up to 50%
of the total cost (instead of 80%).
Apart from financial support, technical assistance (for example access to empaneled attorneys,
etc.) will also be provided in this scheme.
1. Quality Testing and Certification Support Scheme for startups: Testing and
certification of products for quality and assurance are an important and critical part of
business for startups. However, these costs are high for startups in their formative years.
The Scheme ensures that Government of Maharashtra will be reimbursing a part of
quality testing costs incurred by Startups at NABL or BIS recognised labs.
Under this Scheme, DPIIT-recognized startups incorporated in Maharashtra, with a lifetime
annual revenue in any financial year of less than INR 1 crore and funding of less than INR 3
crores shall be eligible for support of maximum up to INR 2 lakhs, subject to maximum 80%
contribution by MSInS.

Introduction
Patent is a type of intellectual property granted by the patent authority to the inventor for a
limited period of time for exercising monopoly over his specific innovation. A patent is
considered to be an exclusive monopoly right as it excludes others from using, selling,
distributing the invention of innovators. Patent Infringement is illegal as it violates the
exclusive right of the patent holder. It is crucial for individuals and companies to be aware of
patent laws and the consequences of patent infringement. It is important to take steps to protect
one’s own patents, as well as to avoid infringement of the same by others. With technology
rapidly advancing, it has become increasingly important to understand the complexities of
patent infringement and how it affects innovation and progress. This article aims to reflect the
same.
Types of patent infringement
Classification of patent infringement have been discussed hereunder.
Direct infringement
Direct infringement is a most common and obvious form of patent infringement. When a third
party without the permission of the patent holder:
• Commercially uses the invention.
• Reproduces the invention.
• Import a protected idea/ invention in India.
• Selling patented inventions.
• Offer to sell patented inventions.
Direct infringement can either be intentional or unintentional during the term of patent. Only
requirement to be fulfilled is the performance of a substantially deceptive function of an
invented product without obtaining a legal licence from the owner for the usage. For example,
Samsung started using the same manufacturing process as the Apple company for making
phones, without taking permission. This is a direct infringement of a patent existing on the
product, owned by the Apple company.
Literal infringement
Literal infringement is a type of direct infringement in which each and every element or
composition protected by either product or process patent is copied, in other words, a replica
of the original product is used, manufactured, sold or imported.
In the case of Polaroid Corp. vs. Eastman Kodak Co (1986), Polaroid claimed that Kodak had
violated its patent right related to instant photography. The central dispute revolved around
Kodak’s instant photography system, which Polaroid argued had utilised its patented
technology. Polaroid believed that four of its patents related to instant photography, including
the process of developing an instant image and the instant camera itself, were infringed by
Kodak. After a prolonged trial, the court ruled in favour of Polaroid, determining that Kodak
had indeed infringed upon Polaroid’s patents. As a result, Kodak was ordered to stop the
production and sale of its instant photography system and Polaroid was awarded substantial
damages.
Non-literal infringement
Non-literal infringement is also recognised by the name of Doctrine of Equivalence. In this
type of infringement, the alleged invention has to pass through the “Triple Identity Test”. This
means when an invention is similar to the patented invention hence performing significantly
the same function, in the same way and producing the same result, may even differentiate in
name, shape or form, that invention will be said to have caused non-literal infringement of the
previously patented invention.
In the landmark case of Ravi Kamal Bali vs. Kala Tech. & Ors (2008), the plaintiff was granted
patent for ‘tamper lock/seals’ and the defendant constructed a similar kind of product by the
name of ‘Seal Tech’, which had the similar functional features as the plaintiff’s lock. The court
of law had applied the Doctrine of Equivalence, and gave the decision in favour of the plaintiff
stating that both the products had exactly the same function and also was made up from the
same material with the only slight differentiation was of construction which did not constitute
an innovation.
Indirect infringement
Indirect infringement occurs when a third party supports, contributes or promotes the direct
infringement. The infringement can either be accidentally or knowingly.
Induced infringement
Induced infringement involves wilful aiding of the infringing process, with or without any
intention to infringe. In either case, the infringer shall be held liable for infringement. The
aiding can be in the form of:
• Assisting in manufacturing of the product.
• Assembling the patented product without proper licence.
• Providing instructions to third parties on production of product.
• Printing the instructions of patented items and selling them.
• Licensing plans or processes.
Contributory infringement
Contributory infringement is a kind of indirect infringement in which the infringer sells or
supplies the parts of a product used exclusively to manufacture the patented products. The
infringer is held liable even if he doesn’t actively participate in the manufacturing process.
Wilful infringement
Wilful infringement occurs when someone disregards the patent invention voluntarily. The
burden of proof in this case lies on the patent holder. The infringer can take the defence of legal
opinion thoroughly in writing. Three step process for willful infringement are:
• Knowledge about the patented invention,
• Good faith belief that the infringer wouldn’t be liable for patented invention,
• Infringer’s belief is reasonable.
If the wilful infringement is proved, the court can order strong deterrents (3 to 4 times of actual
damage), inclusive of court costs, lawyer’s fees etc.
Burden of proof
The burden of proof in patent infringement originally lies upon the patentee (the plaintiff).
However, TRIPS amended the Patents Act, 1970 by insertion of Section 104A thereby
introducing the concept of “reversed burden of proof”. This signifies that if the subject matter
of patent is a process and results to;
1. A new product, and
2. There is substantial likelihood that an identical product is made by the same process
and the patentee, despite reasonable efforts, failed to determine the process.
Then the burden of proof is on the defendant to prove the non-infringement.
Doctrines related to patent infringement
Doctrine of equivalents
Doctrine of equivalents is a legal rule that is applied to find out the patent infringement. The
doctrine classifies even a minor change to the product as an infringement. In simple words, if
the infringed product performs significantly the same function, in the same way and produces
the same result, then it shall lead to patent Infringement under the doctrine of equivalents.
Limitations to the doctrine of equivalents
1. All elements rule: All the elements of a patented product should be present in the
infringed product.
2. Doctrine of public dedication: This doctrine is applicable when a patentee discloses
publically the subject matter of patent but does not claim it. Anyone can then use it
without fear of infringement.
3. Existence of prior art: Invention already publicly available and known, before filing
of the patent application signifies existence of prior art. In other words, the invention is
not unique or exists already in some form.
4. Prosecution of history estoppel: Also known as File-Wrapper Estoppel, it arises as a
legal defence to infringement. It applies where a patent application amends or cancels
a claim rejected by the Patent Office as unpatentable based upon prior art.
In the landmark case of Graver Tank vs. Linde Air (1950), the disputed patented formulation
was a mixture of alkaline earth metal silicate (using magnesium) and calcium. The accused
used manganese, and silicate but not any alkaline earth metal. Experts stated that manganese
served the purpose of magnesium and was equivalent to it. In this case, the court had opined
that “a person reasonably skilled in his work would have known of the replaceable element“.
Interchanging of magnesium with manganese was obvious to anyone working in the same field
and was an insubstantial change. Therefore the court upheld the finding of patent infringement
under the doctrine of equivalents.
Doctrine of colourable variation
The doctrine is derived from a latin maxim, “Quando aliquid prohibetur ex directo, prohibetur
et per obliquum” which means “what cannot be done directly, should also not be done
indirectly”. According to this doctrine, the practice of making minor changes to a patented
invention in order to invade the patent infringement claims, is substantially considered to be
the same as the patented invention, even though it may have some apparent differences. This
means that an infringer cannot neglect liability by making minute changes to the patented
invention. Some of the factors considered by court in order to decide whether a variation is
colorable or not are provided hereunder:
1. The extent of resemblance between the alleged invention and the accused product or
process.
2. The degree of distinction between the two products or processes.
3. The aim or intended usage of the accused product or process.
4. The competency level of the relevant industry at the time the patent was in use.
5. The level of difficulty involved in creating the accused product or process
6. The level of certainty in the relevant industry.
7. The degree of self-creation or prior knowledge.
8. Proof of Copying or other methods of direct violation of patent infringement.
The case of Pfizer Inc. vs. Cadila Healthcare Ltd (2020), involves a dispute over the patent for
the anti-inflammatory drug Celecoxib. Pfizer alleged that Cadila’s generic version of the drug
infringed Pfizer’s patent, but Cadila argued that its product was different from Pfizer’s product
and therefore did not infringe the patent. The Supreme Court of India found that Cadila’s
product was a colorable variation of Pfizer’s product, and amounted to infringement.
What acts do not amount to patent infringement
There are several acts that does not amount to infringement-
1. Independent invention: The impugned product or process was independently
developed by the accused party, without any reference to or use of the claimed invention
of the patent. To prove independent invention, the accused party typically needs to
provide evidence of their invention, such as records of their development activities,
laboratory notebooks, or testimony from witnesses. This evidence should demonstrate
that the accused party was working on the same problem as the patent holder and arrived
at the same solution independently and without reference to the claimed invention of
the patent.
2. Patent expiration: When a patent expires, the inventor’s exclusive rights to the
invention are no longer in effect and anyone may use the invention without infringing
the [Link] term of a patent is typically set by law and is typically 20 years from the
filing date of the patent application. After the patent has expired, the claimed invention
becomes part of the public domain and can be freely used by anyone without fear of
infringing the [Link] prove that the patent has expired, the accused party can
typically provide evidence of the filing date of the patent and the relevant patent law to
demonstrate that the patent has reached the end of its term.
3. Research and experimentation: Experimental use of a patented invention for the
purpose of testing or evaluating it is not considered infringement. In other words, the
accused party is claiming that they were using the claimed invention to test and evaluate
its performance, and that they did not intend to sell or otherwise commercially exploit
the invention.
 4. Government use: In many countries, the government has the right to use a patented
invention without infringing the patent for the purpose of fulfilling its responsibilities
and providing services to the public. The accused product or process is used by or on
behalf of the government and is therefore not subject to the patent. This defence is based
on the idea that the government should have the right to use patented inventions for
various public purposes, such as for national security or for the provision of essential
services, without being subject to infringement claims.
5. Prior use: If a person has been using a patented invention before the patent was
granted, they may be able to continue using it without infringing the patent, depending
on the laws of the relevant jurisdiction. To prove prior use, the accused party typically
needs to provide evidence of their use of the accused product or process before the
filing date of the patent.
6. Fair use: The concept of fair use allows for limited use of a patented invention for
purposes such as criticism, commentary, news reporting, teaching, scholarship, or
research. The defence is based on the idea that certain uses of a patented invention
should be allowed without infringing the patent, even if they would otherwise be
considered infringing, in order to promote the public good and encourage creative and
intellectual activity. To prove fair use, the accused party typically needs to show that
their use of the patented invention was for a permissible purpose under copyright law
and that it was reasonable in scope and impact.
7. First sale doctrine: The first sale doctrine, also known as the exhaustion doctrine,
provides that the sale of a patented item by the patent holder or with their authorization
exhausts their patent rights and allows the buyer to use or resell the item without
infringing the patent. The doctrine is based on the idea that the patent holder’s exclusive
rights to the patented invention are limited and that the rights of others to use, sell, or
distribute a patented product should not be unduly restricted. The first sale doctrine is
often invoked in cases involving the resale of patented products, such as used books,
CDs, or other products that were legally obtained through a sale or transfer. By applying
the first sale doctrine, these products can be resold or otherwise distributed without
infringing the patent, provided that the product was not altered or modified in a way
that would give rise to a new patent infringement.
8. Invalidity or unenforceability of the patent: If a patent is found to be invalid or
unenforceable, any act that would have otherwise constituted infringement would not
be considered infringing.
Defences available against patent infringement
1. Estoppel: Estoppel is a legal principle that can be used as a defence against a claim of
patent infringement. The principle of estoppel states that a person cannot assert a right
that they have previously renounced or abandoned. In the context of patent
infringement, estoppel can be used as a defence when the patent holder has made
statements or taken actions that indicate that they do not believe the accused party is
infringing their patent. For example, if the patent holder has licensed the accused party
to use the patented invention or has allowed the accused party to use the patented
invention for a significant period of time without asserting their patent rights, the patent
 holder may be stopped from later claiming that the accused party is infringing their
patent.
2. Licence: A licence is a legally binding agreement between the patent owner and another
party, in which the patent owner grants the other party permission to use the patented
invention in exchange for some form of compensation. In the context of a patent
infringement claim, a licence defence argues that the accused product or process is
being used under a licence or other agreement with the patent owner that permits the
use. This means that the accused party has a right to use the patented invention, and
therefore cannot be held liable for infringing the patent.
3. Plaintiff is not entitled to sue: The plaintiff who is claiming patent infringement does
not have the legal right to bring a lawsuit for the infringement. This defence can be
raised for a variety of reasons, such as lack of standing, assignment of the patent,
invalidity of the patent, statute of limitations, or a settlement or licensing agreement.
For example, if the patent has been assigned to someone else, the original owner is no
longer entitled to sue for infringement and the new owner must bring the lawsuit
instead. Similarly, if the patent is found to be invalid, the plaintiff is not entitled to sue
for infringement as they do not have a valid patent to enforce.
Remedies for patent infringement
Section 108 of Patent Act,1970 deals with the “Reliefs in suit for infringement”. The remedies
for a suit filed in the infringement of a patent can be classified into three types, they are:
1. Injunction: In the context of patent infringement, an injunction is a court order that
requires the infringing party to stop making, using, selling, or importing the infringing
product. It is a preventative measure that aims to preserve the value of the patent and
prevent further harm to the patent holder. To obtain an injunction, the patent holder
must prove that their patent is valid and that it has been infringed upon by the defendant.
Injunction is of three kinds:
• Temporary Injunction: It is a kind of temporary remedy that is provided before the
final verdict of the case. It is used to preserve the status quo of the patent holder.
Moreover, they are likely to succeed in their lawsuit and will suffer irreparable harm if
the infringing activity is allowed to continue. The court should consider three factors
before granting temporary injunction to the patent holder-
I. Prime facie case.
II. Balance of inconvenience.
III. Irreparable loss
• Permanent injunction: It is a kind of permanent remedy that is granted when the case
is finally decided by the court. It requires the infringing party to stop the infringing
activity permanently. The court may also award monetary damages, such as
compensation for any profits that the infringing party has made as a result of the
infringing activity. To obtain a permanent injunction, the patent holder must file a
lawsuit and prove that their patent is valid and that it has been infringed upon by the
defendant. However, obtaining a permanent injunction can be a complex and time-
 consuming process, and the patent holder must have strong evidence to support their
claim.
• Ex-parte injunction: An ex-parte injunction is a provisional remedy that is used in
urgent situations and is granted without a hearing. It is a powerful remedy for patent
infringement, but it must be used with caution, as it may result in harm to the defendant
if it is later found to be unjustified. It is typically used in urgent situations where the
plaintiff needs immediate relief and there is not enough time for a full hearing.
2. Damages: Damages is a remedy for patent infringement that compensates the patent
holder for any harm that they have suffered as a result of the infringing activity.
Damages may be awarded in the form of monetary compensation, such as compensation
for any lost profits or other financial losses that the patent holder has suffered. The main
objective of damages is to compensate for the loss or injury that happened to the
plaintiff.
3. Seizure, forfeiture or destruction: Courts may decree that the items determined to be
infringing should be taken into custody, forfeited, or disposed of as deemed appropriate.
 UNIT III BIOSAFETY 9
Introduction – Historical Background – Introduction to Biological Safety Cabinets – Primary
Containmentfor Biohazards – Biosafety Levels – Biosafety Levels of Specific Microorganisms –
Recommended Biosafety Levels for Infectious Agents and Infected Animals – Biosafety guidelines –
Government of India.

Biosafety is the prevention of large-scale loss of biological integrity, focusing both on ecology and human
health. These prevention mechanisms include conduction of regular reviews of the biosafety in laboratory
settings, as well as strict guidelines to follow. Biosafety is used to protect from harmful incidents. Many
laboratories handling biohazards employ an ongoing risk managementassessment and enforcement process
for biosafety. Failures to follow such protocols can lead to increased risk of exposure to biohazards or
pathogens. Human error and poor technique contribute tounnecessary exposure and compromise the best
safeguards set into place for protection. The international Cartagena Protocol on Biosafety deals primarily
with the agricultural definition but many advocacy groups seek to expand it to include post-genetic threats:
new molecules, artificial lifeforms, and even robots which may compete directly in the natural food chain.
Biosafety level refers to the stringency of biocontainment precautions deemed necessary by the Centers for
Disease Control and Prevention (CDC) for laboratory work with infectious materials. Typically, institutions
that experiment with or create potentially harmful biologicalmaterial will have a committee or board of
supervisors that is in charge of the institution's biosafety. They create and monitor the biosafety standards
that must be met by labs in order to prevent the accidental release of potentially destructive biological
material. (note that in the US, several groups are involved, and efforts are being made to improve processes
for government run labs, but there is no unifying regulatory authority for all labs.

Biosafety is related to several fields:

1. In ecology (referring to imported life forms from beyond ecoregion borders),

2. In agriculture (reducing the risk of alien viral or transgenic genes, genetic engineering or
prions such as BSE/"MadCow", reducing the risk of food bacterial contamination)
3. In medicine (referring to organs or tissues from biological origin, or genetic therapy products,virus;
levels of lab containment protocols measured as 1, 2, 3, 4 in rising order of danger),
4. In chemistry (i.e., nitrates in water, PCB levels affecting fertility)

5. In exobiology (i.e., NASA's policy for containing alien microbes that may exist on space samples)
In synthetic biology (referring to the risks associated with this type of lab practice). When biological
warfare or new, currently hypothetical, threats (i.e., robots, new artificial bacteria)are considered,
biosafety precautions are generally not sufficient. (link to incident report, i.e.,such as problems with
CDC research labs in 2014). The new field of biosecurity addresses these complex threats.

Hazards:

1. Chemical hazards typically found in laboratory settings include carcinogens, toxins,

irritants,corrosives, and sensitizers.

2. Biological hazards include viruses, bacteria, fungi, prions, and biologically-derived

toxins, which may be present in body fluids and tissue, cell culture specimens, and
laboratory animals. Routes of exposure for chemical and biological hazards include
inhalation, ingestion,skin contact, and eye contact.

3. Physical hazards include ergonomic hazards, ionizing and non-ionizing radiation,

and noise hazards. Additional safety hazards include burns and cuts from autoclaves,
injuries from centrifuges, compressed gas leaks, cold burns from cryogens, electrical
hazards, fires, injuriesfrom machinery, and falls.
In synthetic biology:

A complete understanding of experimental risks associated with synthetic biology is

helping to enforce the knowledge and effectiveness of biosafety. With the potential future creation of
man-made unicellular organisms, some are beginning to consider the effect that these organisms will
have on biomass already present. Scientists estimate that within the next few decades, organism design
will be sophisticated enough to accomplish tasks such as creating biofuels and lowering the levels of
harmful substances in the atmosphere. Scientist that favor the development of synthetic biology claim
that the use of biosafety mechanisms such as suicide genes and nutrient dependencies will ensure the
organisms cannot survive outside of the lab setting in which they were originally created.
Organizations like the ETC Group argue that regulations should control the creation of organisms
that could potentially harm existing life. They also argue that the development of these organisms
will simply shift the consumption of petroleum to the utilization of biomass in order to create energy.
These organisms can harm existing life by affecting the prey/predator food chain, reproduction
between species, as well as competition against other species (species at risk, or act as an invasive
species). Synthetic vaccines are now being produced in the lab. These have caused a lot of excitement
in the pharmaceutical industry as they will be cheaper to produce, allow quicker production, as well
as enhance the knowledge of virology and immunology.
In medicine, healthcare settings and laboratories:

Biosafety, in medicine and health care settings, specifically refers to proper handling of
organs or tissues from biological origin, or genetic therapy products, viruses with respect to the
environment, to ensure the safety of health care workers, researchers, lab staff, patients, and the
general public. Laboratories are assigned a biosafety level numbered 1 through 4 based on their
potential biohazard risk level. The employing authority, through the laboratory director, is
responsible for ensuring that there is adequate surveillance of the health of laboratory personnel. The
objective of such surveillance is to monitor for occupationally acquired diseases. The World Health
Organization attributes human error and poor technique as the primary cause of mishandling of
biohazardous materials.
 Biosafety is also becoming a global concern and requires multilevel resources and
international collaboration to monitor, prevent and correct accidents from unintended and malicious
release and also to prevent that bioterrorists get their hands-on biologics sample to create biologic
weapons of mass destruction. Even people outside of the health sector needs to be involved as in the
case of the Ebola outbreak the impact that it had on businesses and travel required that private sectors,
international banks together pledged more than $2 billion to combat the epidemic. The bureau of
international Security and nonproliferation (ISN) is responsible for managing a broad range of U.S.
nonproliferation policies, programs, agreements, and initiatives, and biological weapon is one their
concerns Biosafety has its risks and benefits. All stakeholders must try to find a balance between
cost-effectiveness of safety measures and use evidence-based safety practices and recommendations,
measure the outcomes and consistently reevaluate the potential benefits that biosafety represents for
human health. Biosafety level designations are based on a composite of the design features,
construction, containment facilities, equipment, practices and operational procedures required for
working with agents from the various risk groups.

Classification of biohazardous materials is subjective and the risk assessment is determined

by the individuals most familiar with the specific characteristics of the organism. There are several
factors taken into account when assessing an organism and the classification process.

1. Risk Group 1: (no or low individual and community risk) A microorganism that is unlikely
to cause human or animal disease.

2. Risk Group 2: (moderate individual risk, low community risk) A pathogen that can cause
human or animal disease but is unlikely to be a serious hazard to laboratory workers, the
community, livestock or the environment. Laboratory exposures may cause serious infection,
but effective treatment and preventive measures are available and the risk of spread of
infection is limited.

3. Risk Group 3: (high individual risk, low community risk) A pathogen that usually causes
serious human or animal disease but does not ordinarily spread from one infected individual
to another. Effective treatment and preventive measures are available.
4. Risk Group 4: (high individual and community risk) A pathogen that usually causes serious human or animal
disease and that can be readily transmitted from one individual to another, directly or indirectly. Effective
treatment and preventive measures are not usually available.

Investigations have shown that there are hundreds of unreported biosafety accidents, with laboratories self-policing
the handling of biohazardous materials and lack of reporting. Poor record keeping, improper disposal, and
mishandling biohazardous materials result in increased risks of biochemical contamination for both the public and
environment. Along with the precautions taken during the handling process of biohazardous materials, the World
Health Organization recommends:Staff training should always include information on safe methods for highly
hazardous procedures that are commonly encountered by all laboratory personnel and which involve:

1. Inhalation risks (i.e. aerosol production) when using loops, streaking agar plates,
2. pipetting, making smears, opening cultures, taking blood/serum samples, centrifuging,
etc.
3. Ingestion risks when handling specimens, smears and cultures
4. Risks of percutaneous exposures when using syringes and needles
5. Bites and scratches when handling animals
6. Handling of blood and other potentially hazardous pathological materials
7. Decontamination and disposal of infectious material.

BIOLOGICAL SAFETY CABINETS

A biosafety cabinet (BSC)—also called a biological safety cabinet or microbiological safety

cabinet—is an enclosed, ventilated laboratory workspace for safely working with materials
contaminated with (or potentially contaminated with) pathogens requiring a defined biosafety level.
Several different types of BSC exist, differentiated by the degree of biocontainment required. BSCs
first became commercially available in 1950.

The primary purpose of a BSC is to serve as a means to protect the laboratory worker and the
surrounding environment from pathogens. All exhaust air is HEPA-filtered as it exits the biosafety
cabinet, removing harmful bacteria and viruses. This is in contrast to a laminar flow clean bench,
which blows unfiltered exhaust air towards the user and is not safe for work with pathogenic agents.
Neither are most BSCs safe for use as fume hoods. Likewise, a fume hood fails to provide the
environmental protection that HEPA filtration in a BSC would provide. However, most classes of
BSCs have a secondary purpose to maintain the sterility of materials inside (the "product").
Classes:

Class 1: Class I cabinets provide personnel and environmental protection but no product protection. In fact,
the inward flow of air can contribute to contamination of samples. Inwardairflow is maintained at a
minimum velocity of 75 ft/min (0.38 m/s). These BSCs are commonly used to enclose specific equipment
(e.g. centrifuges) or procedures (e.g. aerating cultures) that potentially generate aerosols. BSCs of this class
are either ducted (connected tothe building exhaust system) or unducted (recirculating filtered exhaust back
into the laboratory).

Class 2: Class II cabinets provide both kinds of protection (of the samples and of the environment)
since makeup air is also HEPA-filtered. There are five types: Type A1 (formerlyA), Type A2 (formerly
A/B3), Type B1, Type B2 and Type C1. Each type's requirements aredefined by NSF International
Standard 49, which in 2002 reclassified A/B3 cabinets (classified under the latter type if connected
to an exhaust duct) as Type A2, and added the Type C1 in the 2016 standard. About 90% of all
biosafety cabinets installed are Type A2 cabinets. Principles of operation use motor driven blowers
(fans) mounted in the cabinet to draw directional mass airflow around a user and into the air grille -
protecting the operator. The air is then drawn underneath the work surface and back up to the top of
the cabinet whereit passes through the HEPA filters. A column of HEPA filtered, sterile air is also
blown downward, over products and processes to prevent contamination. Air is also exhausted
through a HEPA filter, and depending on the Type of Class II BSC, the air is either recirculated back
into the laboratory or pulled by an exhaust fan, through ductwork where it is expelled from the
building. The Type A1 cabinet, formerly known as Type A, has a minimum inflow velocity of 75
ft/min. The downflow air, considered contaminated, splits just above the work surface (the BSCs
smoke split) and mixes with the inflow. This air is drawn, through ductwork, up the back of the
cabinet where it is then blown into a positive pressure, contaminated plenum. Here, the air is either
recirculated, through a HEPA filter, back down over the work zone, or exhausted out of the cabinet
(also through a HEPA filter).Sizing of HEPA filters and an internal damper are used to balance these
air volumes. This type is not safe for work with hazardous chemicals even when exhausted with a
"thimble" orcanopy to avoid disturbing internal air flow. The Type A2 cabinet, formerly designated
A/B3,has a minimum inflow velocity of 100 ft/min. A negative air pressure plenum surrounds all
contaminated positive pressure plenums. In other respects, the specifications are identical to those of
a Type A1 cabinet. Type B1 and B2 cabinets have a minimum inflow velocity of 100ft/min, and these
cabinets must be hard-ducted to an exhaust system rather than exhausted through a thimble
connection. Their exhaust systems must also be dedicated (one BSC per duct run, per blower). In
contrast to the type A1 and A2 cabinets, Type B BSCs use single pass airflow (air that does not mix
and recirculate) in order to also control hazardous chemicalvapors. Type B1 cabinets split the airflow
so that the air behind the smoke-split is directed tothe exhaust system, while air between the operator
and the smoke-split mixes with inflow airand is recirculated as downflow. Since exhaust air is drawn
from the rear grille, the CDC advises that work with hazardous chemistry be conducted in the rear of
the cabinet. This is complicated, since the smoke split (demarking the "rear of the cabinet") is an
invisible line that extends the width of the cabinet (approximately 10-14 inches from the front grille)
and drifts as the internal HEPA filters load with particulate. The Type B2 cabinet (also known as a
Total Exhaust BSC) is expensive to operate because no air is recirculated within. Therefore,this type
is mainly found in such applications as toxicology laboratories, where the ability to safely use
hazardous chemistry is important. Additionally, there is the risk that contaminatedair would flow into
the laboratory if the exhaust system for a Type B1 or B2 cabinet were to fail. To mitigate this risk,
cabinets of these types generally monitor the exhaust flow, shuttingoff the supply blower and sounding
an alarm if the exhaust flow is insufficient. The Type C1BSC was borne out of necessity to control
infectious material, chemical hazards, reduce operating costs and add flexibility in modern
laboratories. The Type C1 moves air by mixinginflow air with the air in the columns of downflow air
marked for recirculation. Air above a clearly delineated section of the work surface is drawn by a
second internal fan where it is exhausted through a HEPA filter. The C1 differs from a Type A in that
it can use this single pass airflow, and when installed in a ducted operating mode, can protect from
hazardous chemistry, like the Type Bs. The C1 also differs from the Type B BSCs in several ways;
(1) it does not require a hard connected, dedicated exhaust system and blower to operate, (2) pending
a risk assessment, the BSC can run for an extended duration to increase operator protection during a
remote exhaust system failure, and (3) Type C1 BSCs can run without being connected to an exhaust
system at all.

Class 3: The Class III cabinet, generally only installed in maximum containment laboratories, is
specifically designed for work with BSL-4 pathogenic agents, providing maximum protection. The
enclosure is gas-tight, and all materials enter and leave through a dunk tank or double-door autoclave.
Gloves attached to the front prevent direct contact with hazardous materials (Class III cabinets are
sometimes called glove boxes). These custom-built cabinets often attach into a line, and the lab
equipment installed inside is usually custom-built as well.
BIOSAFETY LEVELS

A biosafety level (BSL), or pathogen/protection level, is a set of biocontainment precautions required

to isolate dangerous biological agents in an enclosed laboratory facility. The levels of containment
range from the lowest biosafety level 1 (BSL-1) to the highest at level 4 (BSL-4). In the United States,
the Centers for Disease Control and Prevention (CDC) have specified these levels. In the European
Union, the same biosafety levels are defined in a directive. In Canada the fourlevels are known as
Containment Levels. Facilities with these designations are also sometimes givenas P1 through P4 (for
pathogen or protection level), as in the term P3 laboratory.
At the lowest level of biosafety, precautions may consist of regular hand-washing and minimal
protective equipment. At higher biosafety levels, precautions may include airflow systems, multiple
containment rooms, sealed containers, positive pressure personnel suits, established protocols for all
procedures, extensive personnel training, and high levels of security to control accessto the facility.

History:

The first prototype Class III (maximum containment) biosafety cabinet was fashioned in 1943 by
Hubert Kaempf Jr., then a U.S. Army soldier, under the direction of Arnold G. Wedum, Director
(1944–69) of Industrial Health and Safety at the United States Army Biological Warfare Laboratories,
Camp Detrick, Maryland. Kaempf was tired of his MP duties at Detrick and was able to transfer to
the sheet metal department working with the contractor, the H.K. Ferguson Co.

On 18 April 1955, 14 representatives met at Camp Detrick in Frederick, Maryland. The meeting was to
share knowledge and experiences regarding biosafety, chemical, radiological, and industrial safety
issues that were common to the operations at the three principal biological warfare (BW) laboratories
of the U.S. Army. Because of the potential implication of the work conducted at biological warfare
laboratories, the conferences were restricted to top level security clearances. Beginning in 1957, these
conferences were planned to include non-classified sessions as well as classified sessions to enable
broader sharing of biological safety information. It was not until 1964, however, that conferences were
held in a government installation not associated with a biologicalwarfare program.
Over the next 10 years, the biological safety conferences grew to include representatives from all
federal agencies that sponsored or conducted research with pathogenic microorganisms. By 1966, it
began to include representatives from universities, private laboratories, hospitals, and industrial
complexes. Throughout the 1970s, participation in the conferences continued to expand and by 1983
discussions began regarding the creation of a formal organization. The American Biological Safety
Association (ABSA) was officially established in 1984 and a constitution and bylaws were drafted
the same year. As of 2008, ABSA includes some 1,600 members in its professional association.

In 1977 Jim Peacock of the Australian Academy of Science asked Bill Snowdon, then ChiefCSIRO
AAHL if he could have the newly released USA NIH and the British equivalent requirementsfor the
development of infrastructure for bio-containment reviewed by AAHL personnel with a view to
recommending the adoption of one of them by Australian authorities. The review was carried out by
CSIRO AAHL Project Manager Bill Curnow and CSIRO Engineer Arthur Jenkins. They drafted
outcomes for each of the levels of security. AAHL was notionally classified as "substantially beyond
P4". These were adopted by the Australian Academy of Science and became the basis for Australian
Legislation. It opened in 1985 costing $185 million, built on Corio Oval.[9] The Australian Animal
Health Laboratory is a Class 4/ P4 Laboratory.

Levels:

Biosafety Level 1: Biosafety level 1 (BSL-1) is suitable for work with well-characterized agents
which do not cause disease in healthy humans. In general, these agents should pose minimal potential
hazard to laboratory personnel and the environment. At this level, precautions are limited relative to
other levels. Laboratory personnel must wash their hands upon entering and exiting the lab. Research
with these agents may be performed on standardopen laboratory benches without the use of special
containment equipment. However, eatingand drinking are generally prohibited in laboratory areas.
Potentially infectious material mustbe decontaminated before disposal, either by adding a chemical
such as bleach or isopropanol or by packaging for decontamination elsewhere. Personal protective
equipment is only required for circumstances where personnel might be exposed to hazardous
material. BSL-1 laboratories must have a door which can be locked to limit access to the lab.
However, it is not necessary for BSL-1 labs to be isolated from the general building. This level of
biosafety is appropriate for work with several kinds of microorganisms including non-pathogenic
strains of Escherichia coli and Staphylococcus, Bacillus subtilis, Saccharomyces cerevisiae and other
organisms not suspected to contribute to human disease. Due to the relative ease and safety of
maintaining a BSL-1 laboratory, these are the types of laboratories generally used as teaching spaces
for high schools and colleges.

Biosafety Level 2: At this level, all precautions used at Biosafety Level 1 are followed, andsome
additional precautions are taken. BSL-2 differs from BSL-1 in that:

Laboratory personnel have specific training in handling pathogenic agents and are directed by
scientists with advanced training.

Access to the laboratory is limited when work is being conducted.

Extreme precautions are taken with contaminated sharp items.

Certain procedures in which infectious aerosols or splashes may be created are conducted in
biological safety cabinets or other physical containment equipment.

Biosafety level 2 is suitable for work involving agents of moderate potential hazard topersonnel and
the environment. This includes various microbes that cause milddisease to humans, or are difficult to
contract via aerosol in a lab setting. Examples include Hepatitis A, B, and C viruses, human
immunodeficiency virus (HIV), pathogenic strains of Escherichia coli and Staphylococcus,
Salmonella, Plasmodium falciparum, and Toxoplasma gondii.

Biosafety Level 3: Biosafety level 3 is appropriate for work involving microbes which can cause
serious and potentially lethal disease via the inhalation route. This type of work can bedone in clinical,
diagnostic, teaching, research, or production facilities. Here, the precautionsundertaken in BSL-1 and
BSL-2 labs are followed, as well as additional measures including:
 1. All laboratory personnel are provided medical surveillance and offered relevant
immunizations (where available) to reduce the risk of an accidental or unnoticed infection.

2. All procedures involving infectious material must be done within a biological safety cabinet.

3. Laboratory personnel must wear solid-front protective clothing (i.e. gowns that tie inthe back).
This cannot be worn outside of the laboratory and must be discarded or decontaminated after
each use.

4. A laboratory-specific biosafety manual must be drafted which details how the laboratory will
operate in compliance with all safety requirements.

In addition, the facility which houses the BSL-3 laboratory must have certain features to ensure
appropriate containment. The entrance to the laboratory must be separated from areas of the building
with unrestricted traffic flow. Additionally, the laboratory must be behind two sets of self-closing
doors (to reduce the risk of aerosols escaping).The construction of the laboratory is such that it can be
easily cleaned. Carpets are notpermitted, and any seams in the floors, walls, and ceilings are sealed to
allow for easycleaning and decontamination. Additionally, windows must be sealed, and a ventilation
system installed which forces air to flow from the "clean" areas of the lab to the areas where infectious
agents are handled. Air from the laboratory must be filtered before it can be recirculated.

Biosafety level 3 is commonly used for research and diagnostic work involving various microbes
which can be transmitted by aerosols and/or cause severe disease. These include Francisella
tularensis, Mycobacterium tuberculosis, Chlamydia psittaci, Venezuelan equine encephalitis virus,
Eastern equine encephalitis virus, SARS-CoV-1, SARS-CoV-2, MERS-CoV, Coxiella burnetii, Rift
Valley fever virus,Rickettsia rickettsii, several species of Brucella, chikungunya, yellow fever virus,
West Nile virus, Yersinia pestis.
Biosafety Level 4: Biosafety level 4 (BSL-4) is the highest level of biosafety precautions, andis
appropriate for work with agents that could easily be aerosol-transmitted within the laboratory and
cause severe to fatal disease in humans for which there are no available vaccines or treatments. BSL-4
laboratories are generally set up to be either cabinet laboratories or protective-suit laboratories. In
cabinet laboratories, all work must be done within a class III biosafety cabinet. Materials leaving the
cabinet must be decontaminated bypassing through an autoclave or a tank of disinfectant. The
cabinets themselves are required to have seamless edges to allow for easy cleaning. Additionally the
cabinet and all materials within must be free of sharp edges in order to reduce the risk of damage to
the gloves. In a protective-suit laboratory, all work must be done in a class II biosafety cabinet by
personnel wearing a positive pressure suit. In order to exit the BSL-4 laboratory, personnel must pass
through a chemical shower for decontamination, then a room for removing the positive- pressure suit,
followed by a personal shower. Entry into the BSL-4 laboratory is restricted totrained and authorized
individuals, and all persons entering and exiting the laboratory must be recorded. As with BSL-3
laboratories, BSL-4 laboratories must be separated from areas that receive unrestricted traffic.
Additionally airflow is tightly controlled to ensure that air always flows from "clean" areas of the lab
to areas where work with infectious agents is beingperformed. The entrance to the BSL-4 lab must also
employ airlocks to minimize the possibility that aerosols from the lab could be removed from the lab.
All laboratory waste, including filtered air, water, and trash must also be decontaminated before it can
leave the facility. Biosafety level 4 laboratories are used for diagnostic work and research on easily
transmitted pathogens which can cause fatal disease. These include a number of viruses known to
cause viral hemorrhagic fever such as Marburg virus, Ebola virus, Lassa virus, andCrimean-Congo
hemorrhagic fever. Other pathogens handled at BSL-4 include Hendra virus,Nipah virus, and some
flaviviruses. Additionally, poorly characterized pathogens which appear closely related to dangerous
pathogens are often handled at this level until sufficient data are obtained either to confirm continued
work at this level, or to permit working with them at a lower level. This level is also used for work
with Variola virus, the causative agentof smallpox, though this work is only performed at the
Centers for Disease Control and Prevention in Atlanta, United States, and the State Research Center
of Virology andBiotechnology in Koltsovo, Russia.
 UNIT IV GENETICALLY MODIFIED ORGANISMS 9
Definition of GMOs & LMOs – Roles of Institutional Biosafety Committee – RCGM –
GEAC etc. for GMO applications in food and agriculture – Environmental release of
GMOs – Risk Analysis – Risk Assessment – Risk management and communication –
Overview of National Regulations and relevantInternational Agreements including
Cartegana Protocol.

Definition of GMOs & LMOs

Genetically Modified Organisms (GMOs):
GMOs are organisms (plants, animals, microorganisms) whose genetic material has been
altered using genetic engineering techniques. This modification is done to introduce desired
traits such as resistance to pests, diseases, or environmental conditions, improved nutritional
content, or enhanced growth rates. The techniques used in creating GMOs can include gene
cloning, gene editing (e.g., CRISPR), and recombinant DNA technology.
Examples of GMOs include:
• Genetically modified crops (e.g., Bt cotton, Roundup Ready soybeans) that have been
engineered for pest resistance or herbicide tolerance.
• Genetically modified microorganisms used in pharmaceuticals or industrial
applications, such as insulin-producing bacteria.

Living Modified Organisms (LMOs):

LMOs refer to any living organism that has been modified through modern biotechnology,
where the changes are introduced in a way that is not possible through traditional breeding
methods. This term is often used in international agreements, such as the Cartagena Protocol
on Biosafety, to encompass a broader range of organisms modified using biotechnological
techniques, including GMOs.
LMOs include:
• Any modified organisms that can reproduce or replicate, which can include plants,
animals, and microorganisms.
• Organisms whose genetic material has been altered but do not necessarily have
characteristics intended for agricultural or pharmaceutical purposes.

Key Differences
• Scope: All GMOs are LMOs, but not all LMOs are GMOs. The term "LMOs" is broader
 and includes any living organism that has undergone modification, while "GMO"
specifically refers to organisms with genetic material altered for specific traits or
purposes.
• Context: The term "GMO" is often used in agricultural and industrial contexts, while
"LMO" is commonly used in legal and regulatory frameworks, particularly in
international agreements concerning biosafety and trade.
ROLES OF INSTITUTIONAL BIOSAFETY COMMITTEE
The Institutional Biosafety Committee (IBC) plays a crucial role in overseeing research and
activities involving genetically modified organisms (GMOs) and ensuring that they are
conducted safely and ethically. The specific roles and responsibilities of the IBC can vary by
institution and country, but they generally include the following key functions:
1. Review of Research Proposals
• The IBC reviews research proposals involving GMOs to assess their scientific validity,
safety, and compliance with applicable biosafety regulations and guidelines.
• The committee evaluates the potential risks associated with the proposed research and
determines whether the benefits outweigh those risks.
2. Assessment of Biosafety Protocols
• The IBC assesses the biosafety protocols and containment measures proposed by
researchers to mitigate risks to human health and the environment.
• It ensures that appropriate biosafety levels (BSL) are established and followed in
laboratory settings, depending on the nature of the organisms being used.
3. Monitoring Compliance
• The committee monitors ongoing research activities to ensure compliance with
approved biosafety protocols and regulatory requirements.
• Regular inspections and audits may be conducted to verify adherence to safety practices
and standards.
4. Education and Training
• The IBC is responsible for educating and training researchers, laboratory personnel,
and staff on biosafety practices, risk assessment, and compliance with regulations.
• Training programs may cover topics such as safe handling of GMOs, emergency
procedures, and waste disposal protocols.
5. Reporting and Documentation
• The IBC is required to maintain thorough records of all research proposals, approvals,
monitoring activities, and incidents related to biosafety.
 • The committee may also be responsible for reporting significant findings, incidents, or
non-compliance to relevant regulatory authorities.
6. Public Engagement and Transparency
• The IBC may engage with the public and stakeholders to promote transparency and
address concerns related to GMO research and safety.
• The committee may organize public meetings or forums to communicate the benefits
and risks associated with GMOs.
7. Advisory Role
• The IBC serves as an advisory body to the institution's administration regarding
biosafety policies, regulations, and ethical considerations.
• It may provide recommendations for the development of institutional biosafety policies
and procedures.
8. Collaboration with Regulatory Bodies
• The IBC works closely with national and international regulatory bodies (e.g., the
Genetic Engineering Appraisal Committee (GEAC) in India) to ensure compliance with
legal requirements related to GMOs and biosafety.
• The committee may facilitate the submission of necessary documentation and approvals
required for research involving GMOs.
RCGM
The Review Committee on Genetic Manipulation (RCGM) is a critical regulatory body in India
responsible for overseeing research and development activities involving genetically modified
organisms (GMOs) and ensuring biosafety in biotechnology research. Here are the key roles,
functions, and responsibilities of the RCGM:
Roles and Responsibilities of RCGM
1. Review of Research Proposals:
o The RCGM evaluates applications and proposals related to research involving
GMOs and LMOs (Living Modified Organisms) submitted by institutions and
researchers.
o The committee assesses the scientific merit, safety, and ethical considerations
of the proposed research projects.
2. Biosafety Assessment:
o The RCGM conducts a thorough risk assessment to evaluate potential risks to
human health and the environment associated with the proposed research.
o It ensures that appropriate biosafety measures are proposed to mitigate
 identified risks.
3. Approval of Containment Facilities:
o The committee is responsible for approving the containment facilities where
GMOs are to be handled. This includes evaluating the design, operation, and
safety features of the facilities.
o It determines the appropriate biosafety levels (BSL) required for the activities
proposed.
4. Monitoring of Research Activities:
o The RCGM monitors ongoing research projects involving GMOs to ensure
compliance with approved protocols and regulatory guidelines.
o It may conduct inspections and audits to verify adherence to biosafety standards
and practices.
5. Advisory Role:
o The RCGM provides guidance and recommendations to the Ministry of
Environment, Forest and Climate Change (MoEF&CC) and other relevant
authorities regarding policies and regulations related to genetic manipulation
and biotechnology.
o It may advise on the development of guidelines and frameworks for biosafety
assessments.
6. Collaboration with Other Regulatory Bodies:
o The RCGM works in conjunction with the Genetic Engineering Appraisal
Committee (GEAC), which is the apex body for granting approvals for GMOs
in India.
o It facilitates communication and coordination between various stakeholders
involved in biotechnology research.
7. Public Consultation and Awareness:
o The RCGM may engage with the public and stakeholders to promote awareness
and understanding of GMOs, their potential benefits, and associated risks.
o It may organize workshops, seminars, and public consultations to address
concerns related to genetic manipulation.
8. Documentation and Reporting:
o The RCGM is responsible for maintaining detailed records of applications
reviewed, approvals granted, monitoring activities, and incidents related to
GMOs.
 o It may be required to submit periodic reports to the MoEF&CC on its activities
and findings.
GEAC
The Genetic Engineering Appraisal Committee (GEAC) is a key regulatory body in India
responsible for overseeing activities related to genetically modified organisms (GMOs) and
ensuring their safe use in various applications, including agriculture, pharmaceuticals, and
research. Established under the Ministry of Environment, Forest and Climate Change
(MoEF&CC), the GEAC plays a critical role in the biosafety assessment and regulation of
GMOs. Here are the key roles, functions, and responsibilities of the GEAC:
Roles and Responsibilities of GEAC
1. Approval of GMOs and LMOs:
o The GEAC is responsible for granting approval for the release and
commercialization of GMOs and LMOs (Living Modified Organisms) into the
environment and for use in agriculture and other applications.
o This includes evaluating the safety and efficacy of genetically engineered crops,
microorganisms, and other products before they can be marketed or released.
2. Assessment of Biosafety Data:
o The committee reviews biosafety data submitted by research institutions and
companies regarding the potential risks associated with GMOs, including
impacts on human health and the environment.
o It conducts a comprehensive assessment to determine whether the benefits of
the GMO outweigh any potential risks.
3. Policy Formulation and Guidance:
o The GEAC provides guidance and recommendations to the government
regarding policies and regulations related to genetic engineering and
biotechnology.
o It helps shape the legal framework governing the use and regulation of GMOs
in India.
4. Monitoring and Compliance:
o The committee monitors compliance with approved protocols and guidelines
during the research, development, and commercialization of GMOs.
o It ensures that organizations working with GMOs adhere to biosafety standards
and report any adverse events or incidents.
5. Coordination with Other Regulatory Bodies:
 o The GEAC collaborates with various stakeholders, including the Review
Committee on Genetic Manipulation (RCGM), state governments, research
institutions, and international regulatory bodies.
o This collaboration helps facilitate effective regulation and oversight of GMOs.
6. Public Engagement and Awareness:
o The GEAC engages with the public and stakeholders to promote awareness and
understanding of GMOs, their potential benefits, and associated risks.
o It may organize workshops, seminars, and public consultations to address
concerns and provide information on biotechnology and biosafety.
7. Documentation and Reporting:
o The GEAC is responsible for maintaining comprehensive records of
applications received, approvals granted, and monitoring activities.
o It may also be required to submit periodic reports to the Ministry of
Environment regarding its activities and findings.
8. Risk Communication:
o The committee plays a role in communicating risks associated with GMOs to
the public, stakeholders, and policymakers.
o It aims to ensure that information regarding GMOs is transparent and accessible,
promoting informed decision-making.

GMO APPLICATIONS IN FOOD AND AGRICULTURE

Genetically Modified Organisms (GMOs) have a wide range of applications in food and
agriculture, offering numerous benefits and innovations aimed at improving crop production,
enhancing food quality, and addressing various agricultural challenges. Here are some key
applications of GMOs in these fields:
1. Improved Crop Yield
• Enhanced Resistance to Pests: GMOs are engineered to express genes from natural
insecticides (e.g., Bacillus thuringiensis or Bt) that protect plants from insect pests. This
reduces the need for chemical pesticides and helps increase crop yield.
• Disease Resistance: Genetic modifications can make crops resistant to various diseases
caused by fungi, bacteria, and viruses, leading to reduced crop loss and increased
production.
2. Herbicide Tolerance
• Resistance to Herbicides: Many GMOs are engineered to withstand specific herbicides,
 allowing farmers to apply these chemicals without harming the crop. This enables better
weed control, reducing competition for nutrients and water.
3. Nutritional Enhancement
• Biofortification: GMOs can be designed to enhance their nutritional content. For
example, Golden Rice has been engineered to contain higher levels of Vitamin A,
addressing deficiencies in populations that rely on rice as a staple food.
• Improved Nutritional Profiles: Other GMOs are developed to contain beneficial
nutrients, such as omega-3 fatty acids in oilseeds, to improve human health.
4. Drought and Stress Tolerance
• Environmental Resilience: GMOs can be engineered to withstand environmental
stresses such as drought, salinity, and extreme temperatures. This is particularly
important in the context of climate change, where weather patterns are becoming
increasingly unpredictable.
5. Extended Shelf Life and Food Quality
• Longer Shelf Life: Genetic modifications can slow down ripening and spoilage
processes in fruits and vegetables, extending their shelf life and reducing food waste.
• Improved Taste and Quality: GMOs can be developed to enhance flavor, texture, and
other quality attributes in food products.
6. Reduced Allergens and Toxins
• Allergen Reduction: Genetic engineering can help reduce or eliminate allergens in
certain foods. For example, research is ongoing to create peanut varieties with reduced
allergenic properties.
• Toxin Reduction: Some GMOs are developed to lower the levels of naturally occurring
toxins (e.g., aflatoxins) in crops, making them safer for consumption.
7. Sustainable Agriculture
• Reduced Chemical Inputs: By decreasing the need for chemical pesticides and
fertilizers, GMOs can contribute to more sustainable agricultural practices.
• Conservation Tillage: Herbicide-tolerant GMOs enable farmers to adopt conservation
tillage practices, which improve soil health and reduce erosion.
8. Economic Benefits for Farmers
• Cost Savings: Farmers can save money on pest control and herbicides, potentially
leading to higher profits.
• Access to New Markets: Adoption of GMOs can open up new market opportunities, as
certain products may have higher demand or premium pricing.
ENVIRONMENTAL RELEASE OF GMOS
The environmental release of genetically modified organisms (GMOs) refers to the deliberate
introduction of these organisms into the environment, such as in agricultural fields or natural
ecosystems. This process raises various ecological, health, and regulatory concerns, which
necessitate careful assessment and monitoring. Below is an overview of the key aspects related
to the environmental release of GMOs:
1. Types of Environmental Release
• Field Trials: Controlled experimental releases of GMOs are conducted to evaluate their
performance, ecological impact, and agronomic characteristics. These trials are often
conducted under strict regulatory oversight.
• Commercial Release: Once GMOs are approved for commercial use, they can be
released into the environment on a larger scale for agricultural production.
• Unintentional Release: GMOs may also unintentionally enter the environment through
seed spillage, cross-pollination with wild relatives, or contamination during
transportation and processing.
2. Potential Environmental Impacts
• Biodiversity Effects: The introduction of GMOs can affect local biodiversity. For
example, the cultivation of herbicide-tolerant crops may lead to a reduction in non-
target plant species due to herbicide applications, affecting the overall ecosystem.
• Gene Flow: There is a risk of gene flow, where genes from GMOs may transfer to wild
relatives or non-GMO crops through cross-pollination, potentially leading to the
creation of hybrid organisms with unintended traits.
• Impact on Non-Target Species: GMOs engineered to produce insecticidal proteins may
impact non-target species, including beneficial insects and pollinators, altering the
balance of ecosystems.
• Soil Health: The environmental release of GMOs can have effects on soil microbiota
and nutrient cycling. Certain GMOs may change soil composition and microbial
diversity.
3. Regulatory Frameworks
• Pre-Market Assessment: Before environmental release, GMOs must undergo rigorous
assessments to evaluate their potential ecological impacts, including risk assessments
that consider environmental, health, and safety aspects.
• Biosafety Regulations: Various countries have established biosafety regulations to
govern the environmental release of GMOs. These regulations typically require
 extensive data on the potential risks associated with the GMO and may involve public
consultations.
• Monitoring and Surveillance: Post-release monitoring is crucial to assess the
environmental impact of GMOs and to detect any unintended consequences. This may
involve tracking changes in local biodiversity, gene flow, and the effects on non-target
organisms.
4. Public Concerns and Ethical Considerations
• Public Acceptance: The environmental release of GMOs often raises public concerns
regarding safety, ethics, and potential long-term impacts on ecosystems. Community
engagement and transparent communication are essential for addressing these concerns.
• Ethical Considerations: The implications of altering natural ecosystems with GMOs
pose ethical questions about human intervention in nature and the responsibilities
associated with such actions.
5. Benefits of Environmental Release
• Increased Agricultural Productivity: The use of GMOs can lead to higher crop yields
and reduced losses due to pests and diseases, contributing to food security.
• Reduced Chemical Usage: GMOs that are resistant to pests or diseases can reduce the
need for chemical pesticides, leading to lower environmental contamination.
• Adaptation to Climate Change: Certain GMOs are developed to withstand climate-
related stressors, such as drought or salinity, helping to maintain agricultural
productivity in changing environmental conditions.

RISK ANALYSIS
Risk analysis is a systematic process used to identify, assess, and prioritize risks associated
with a particular activity, project, or system, especially when considering the environmental
release of genetically modified organisms (GMOs). In the context of GMOs, risk analysis is
crucial for evaluating potential impacts on human health and the environment before these
organisms are released into the ecosystem. Here’s an overview of the risk analysis process, its
components, and its significance.
1. Components of Risk Analysis
Risk analysis generally involves three main components:
• Risk Assessment: This is the scientific evaluation of the potential adverse effects
resulting from exposure to a hazard. It includes:
o Hazard Identification: Determining whether a GMO poses any potential risks
 (e.g., toxicity, allergenicity, ecological impact).
o Risk Characterization: Describing the nature and magnitude of the risk,
including the likelihood of occurrence and the severity of potential impacts.
o Exposure Assessment: Evaluating the potential exposure pathways and levels
to which humans and the environment may be subjected.
• Risk Management: This involves developing strategies and actions to mitigate
identified risks. It includes:
o Implementing safety measures (e.g., containment protocols, monitoring
programs).
o Establishing regulatory frameworks and guidelines.
o Making informed decisions about whether to proceed with the release of a GMO
and under what conditions.
• Risk Communication: This is the process of sharing information about risks and risk
management strategies with stakeholders, including the public, researchers, regulatory
bodies, and policymakers. Effective communication is vital for transparency and public
acceptance.
2. Steps in Risk Analysis
1. Define the Scope:
o Clearly define the objectives of the risk analysis, including the specific GMOs
under consideration, the intended release environment, and the potential
endpoints of concern.
2. Conduct Hazard Identification:
o Identify potential hazards associated with the GMO, including potential impacts
on human health, non-target organisms, biodiversity, and ecosystem functions.
3. Perform Risk Assessment:
o Carry out detailed evaluations of identified hazards, including laboratory
studies, field trials, and literature reviews to gather data on potential effects and
exposure levels.
4. Evaluate Risk Management Options:
o Assess various risk management strategies to mitigate identified risks, including
pre-release monitoring, containment measures, and post-release monitoring.
5. Implement Risk Management Plans:
o Choose appropriate risk management measures and ensure they are in place
before the environmental release of the GMO.
 6. Monitor and Review:
o Implement monitoring systems to track the effects of the released GMO on
human health and the environment. Regularly review the risk analysis process
and update it as necessary based on new information or incidents.
3. Significance of Risk Analysis
• Public Health Protection: Risk analysis helps ensure that GMOs do not pose
unacceptable risks to human health, allowing for informed decision-making regarding
their use in food and agriculture.
• Environmental Conservation: By assessing potential ecological impacts, risk analysis
contributes to the protection of biodiversity and ecosystem integrity.
• Regulatory Compliance: Risk analysis is a fundamental requirement in many regulatory
frameworks for the approval of GMOs, ensuring compliance with safety standards.
• Facilitating Innovation: By providing a structured approach to evaluating risks, risk
analysis can help foster responsible innovation in biotechnology, encouraging the
development of new GMOs that offer societal benefits.
• Building Public Trust: Transparent and thorough risk analysis enhances public
confidence in the safety of GMOs, addressing concerns and promoting acceptance of
biotechnological advancements.
– RISK ASSESSMENT
Risk assessment is a critical component of the risk analysis process, particularly in the context
of genetically modified organisms (gmos). It involves a systematic evaluation of potential
adverse effects that may arise from the use or release of gmos into the environment or human
food systems. The aim of risk assessment is to identify, characterize, and quantify risks to
human health and the environment, providing a scientific basis for regulatory decision-making
and risk management. Here’s an overview of the risk assessment process for gmos, its
components, and its importance.
1. Components of Risk Assessment
Risk assessment generally consists of four main steps:
1. Hazard Identification:
o This step involves determining whether the GMO poses any potential hazards
to human health or the environment. It includes:
▪ Reviewing data from laboratory studies, field trials, and literature on
similar gmos or traits.
▪ Identifying potential risks such as toxicity, allergenicity, ecological
 impacts, or unintended consequences.
2. Risk Characterization:
o In this step, the nature and magnitude of identified risks are evaluated. It
includes:
▪ Qualitative and Quantitative Analysis: Assessing both the qualitative
and quantitative aspects of risk. This may involve determining the
likelihood of adverse events occurring and the severity of their potential
impacts.
▪ Exposure Assessment: Evaluating the pathways through which humans
or environmental organisms may be exposed to the GMO, including the
duration and extent of exposure.
▪ Characterizing the risks based on the likelihood of occurrence and the
consequences associated with those risks.
3. Exposure Assessment:
o This involves determining the extent to which humans and the environment may
be exposed to the GMO. Key considerations include:
▪ Routes of Exposure: Identifying how exposure may occur, such as
through consumption of food, environmental release, or contact with
non-target organisms.
▪ Exposure Levels: Estimating the concentrations and amounts of the
GMO that may enter the environment or food supply and the duration
of that exposure.
4. Risk Estimation:
o This step integrates the information from hazard identification, risk
characterization, and exposure assessment to estimate the overall risk associated
with the GMO. It may involve:
▪ Modeling potential outcomes based on different scenarios.
▪ Developing risk profiles for various contexts of use (e.g., agricultural
settings, open environments).
2. Importance of Risk Assessment
• Scientific Basis for Decision-Making: Risk assessment provides a scientific framework
for evaluating the safety of gmos, informing regulatory decisions regarding their
approval and commercialization.
• Public Health Protection: By assessing potential health risks associated with gmos, risk
 assessment helps protect consumers from potential hazards in food and environmental
exposure.
• Environmental Protection: It plays a vital role in evaluating the ecological impact of
gmos, ensuring that biodiversity and ecosystem integrity are preserved.
• Regulatory Compliance: Risk assessment is often a legal requirement in many countries
before the approval of gmos, helping to ensure that all necessary safety evaluations are
conducted.
• Promoting Transparency and Trust: A transparent and rigorous risk assessment process
fosters public confidence in the safety of gmos, addressing concerns and enabling
informed discussions about biotechnology.
3. Methodologies in Risk Assessment
Several methodologies can be employed in the risk assessment process for gmos, including:
• Comparative Risk Assessment: Comparing the risks associated with gmos to those of
conventional breeding methods or existing agricultural practices.
• Quantitative Risk Assessment Models: Utilizing statistical models to estimate
probabilities and impacts of adverse effects based on empirical data.
• Qualitative Risk Assessment: Using expert judgment and qualitative analysis to
evaluate risks when quantitative data may be limited.
4. Challenges in Risk Assessment
• Data Gaps: Insufficient or incomplete data on long-term effects and interactions of
gmos with ecosystems can complicate risk assessment.
• Uncertainty: Inherent uncertainties related to biological interactions, ecological
dynamics, and human behavior can affect risk estimates.
• Public Perception: Public concerns and perceptions about gmos can influence the risk
assessment process and its outcomes, necessitating effective communication and
engagement strategies.
RISK MANAGEMENT AND COMMUNICATION
Risk management and communication are essential components of the overall risk analysis
process, particularly in the context of genetically modified organisms (GMOs). These
processes ensure that identified risks are effectively mitigated and that relevant information is
communicated transparently to stakeholders, including the public, regulatory authorities, and
industry partners. Here’s an overview of risk management and communication, their
components, and their significance.
Risk Management
Risk management involves the development and implementation of strategies to minimize
identified risks associated with GMOs, ensuring safety for human health and the environment.
The key steps in risk management include:
1. Risk Mitigation Strategies:
o Implementation of Safety Measures: Establishing protocols and practices to
reduce the likelihood of adverse effects, such as containment measures,
monitoring programs, and safety assessments.
o Use of Regulatory Frameworks: Adhering to established guidelines and
regulations that govern the release and use of GMOs, ensuring compliance with
safety standards.
2. Monitoring and Surveillance:
o Post-Market Monitoring: Continuously tracking the effects of GMOs in the
environment and food supply to detect any unforeseen impacts.
o Data Collection: Gathering data on the performance of GMOs, potential risks,
and ecological impacts to inform ongoing risk management efforts.
3. Adaptive Management:
o Feedback Mechanisms: Incorporating feedback from monitoring and
assessments to update risk management strategies and practices as new
information becomes available.
o Flexibility: Adapting management strategies in response to changing conditions
or unexpected outcomes, ensuring that risk mitigation efforts remain effective
over time.
4. Regulatory Compliance:
o Ensuring that all risk management strategies align with local and international
regulations governing GMOs, fostering accountability and adherence to safety
standards.
Risk Communication
Risk communication refers to the process of sharing information about risks, risk management
strategies, and safety measures with various stakeholders. Effective risk communication is
crucial for building trust and facilitating informed decision-making. Key components of risk
communication include:
1. Clear and Transparent Messaging:
o Providing accessible and understandable information about the risks and
benefits associated with GMOs, including scientific data and regulatory
 assessments.
o Using non-technical language to ensure that information is comprehensible to
diverse audiences.
2. Engagement with Stakeholders:
o Public Engagement: Actively involving the public in discussions about GMOs,
addressing concerns, and soliciting feedback. This may include community
forums, public consultations, and educational outreach.
o Collaboration with Stakeholders: Engaging with farmers, industry
representatives, researchers, and regulatory bodies to share insights, gather
input, and build consensus.
3. Timeliness of Information:
o Ensuring that information is communicated in a timely manner, particularly
during critical decision-making periods or when new findings emerge.
o Regularly updating stakeholders on ongoing research, monitoring results, and
any changes to risk management strategies.
4. Crisis Communication:
o Preparing for and responding to potential crises or adverse events related to
GMOs. This includes having contingency plans in place and being ready to
communicate swiftly and effectively during emergencies.
o Providing accurate and timely information during a crisis to mitigate public
concern and prevent misinformation.
5. Building Trust:
o Establishing credibility through transparency and openness, fostering trust
between stakeholders and regulatory bodies.
o Engaging with the community to understand their values, concerns, and
preferences regarding GMOs, which can inform risk management and
communication strategies.
Significance of Risk Management and Communication
• Public Health and Safety: Effective risk management ensures that potential risks
associated with GMOs are minimized, protecting public health and safety.
• Environmental Protection: Through monitoring and mitigation strategies, risk
management helps preserve biodiversity and ecosystem health in the context of GMO
use.
• Regulatory Compliance: Risk management and communication practices support
 adherence to legal and regulatory requirements, facilitating the responsible use of
GMOs.
• Informed Decision-Making: Clear communication of risks and safety measures enables
stakeholders to make informed choices regarding the use and acceptance of GMOs.
• Enhanced Public Trust: Transparent risk communication fosters trust and confidence
among the public, stakeholders, and regulatory authorities, promoting a positive
dialogue around biotechnology.

OVERVIEW OF NATIONAL REGULATIONS AND RELEVANT

INTERNATIONAL AGREEMENTS INCLUDING CARTEGANA PROTOCOL.
The regulation of genetically modified organisms (gmos) involves a complex framework of
national regulations and international agreements aimed at ensuring the safety of gmos for
human health and the environment. Below is an overview of key national regulations in various
countries, as well as relevant international agreements, including the Cartagena Protocol on
Biosafety.
National Regulations
1. United States:
o Animal and Plant Health Inspection Service (APHIS): Oversees the regulation
of gmos under the Plant Protection Act. APHIS evaluates gmos for potential
risks to agriculture and the environment.
o Food and Drug Administration (FDA): Responsible for assessing the safety of
gmos intended for human consumption, ensuring they meet the same safety
standards as conventional foods.
o Environmental Protection Agency (EPA): Regulates pesticides produced by
gmos, including those that express insecticidal proteins, under the Federal
Insecticide, Fungicide, and Rodenticide Act (FIFRA).
2. European Union:
o European Food Safety Authority (EFSA): Conducts risk assessments for gmos
intended for food and feed. The EU has stringent regulations on GMO
approvals, requiring comprehensive safety evaluations.
o Directive 2001/18/EC: Governs the deliberate release of gmos into the
environment and sets out the procedures for risk assessment, public
consultation, and labeling of GMO products.
o Regulation (EC) No 1829/2003: Concerns the authorization of gmos for food
 and feed use, requiring clear labeling and traceability.
3. India:
o Genetic Engineering Appraisal Committee (GEAC): Under the Ministry of
Environment, Forest and Climate Change, GEAC is responsible for the approval
of gmos for environmental release and commercial use.
o Regulatory Framework: Governed by the Environmental Protection Act, 1986,
and the Rules for the Manufacture, Use, Import, Export, and Storage of
Hazardous Microorganisms/Genetically Engineered Organisms, 1989. The
framework includes guidelines for biosafety assessments and risk management.
4. Australia:
o Office of the Gene Technology Regulator (OGTR): Regulates the release and
use of gmos under the Gene Technology Act 2000. The OGTR conducts risk
assessments and issues licenses for GMO research and commercial use.
o Food Standards Australia New Zealand (FSANZ): Responsible for food safety
assessments related to GM foods and establishing labeling requirements.
International Agreements
1. Cartagena Protocol on Biosafety:
o Overview: The Cartagena Protocol is an international treaty adopted in 2000,
which aims to ensure the safe transfer, handling, and use of living modified
organisms (lmos) resulting from modern biotechnology. It is part of the
Convention on Biological Diversity (CBD).
o Objectives:
▪ Protect biological diversity from potential risks posed by lmos.
▪ Ensure the safety of lmos in international trade and facilitate their
movement between countries.
▪ Promote public awareness and participation in decisions related to the
release of lmos.
o Key Provisions:
▪ Advance Informed Agreement (AIA): Countries must provide prior
consent before lmos can be imported, ensuring that importing countries
are informed of the potential risks.
▪ Risk Assessment and Management: Encourages countries to undertake
risk assessments before the release of lmos into the environment.
▪ Capacity Building: Supports developing countries in strengthening their
 biosafety regulatory frameworks and capabilities.
▪ Biosafety Clearing-House: Establishes a database to facilitate the
exchange of information related to lmos, including risk assessments and
regulatory decisions.
2. Food and Agriculture Organization (FAO):
o The FAO provides guidelines for assessing and managing risks associated with
gmos in food and agriculture. These guidelines promote best practices and
encourage safe use in food production.
3. World Trade Organization (WTO):
o Agreement on the Application of Sanitary and Phytosanitary Measures (SPS
Agreement): Allows countries to set their own food safety standards, including
those related to gmos, but requires that such standards are based on scientific
evidence and do not constitute arbitrary or unjustifiable discrimination
 UNIT V ENTREPRENEURSHIP DEVELOPMENT 9
Introduction – Entrepreneurship Concept – Entrepreneurship as a career – Entrepreneurial personality –
Characteristics of successful Entrepreneur – Factors affecting entrepreneurial growth – Entrepreneurial
Motivation – Competencies – Mobility – Entrepreneurship Development Programmes (EDP) -
Launching Of Small Enterprise - Definition, Characteristics – Relationship between small and large units
– Opportunities for an Entrepreneurial career – Role of small enterprise in economic development –
Problems of small scale industries – Institutional finance to entrepreneurs - Institutional support to
entrepreneurs.
ENTREPRENEURSHIP CONCEPT

Entrepreneurship is the process of designing, launching, and running a new business or venture. It involves
the identification of opportunities, the mobilization of resources, and the execution of plans to create
innovative products or services. Entrepreneurs play a vital role in economic development by driving
innovation, creating jobs, and contributing to the overall growth of society.
Key Components of Entrepreneurship
1. Innovation:
o Entrepreneurship often revolves around the development of new ideas, products, or services.
Innovation can manifest in various forms, such as technological advancements, process
improvements, or new business models. Entrepreneurs are typically characterized by their
ability to think creatively and identify unmet needs in the market.
2. Risk-Taking:
o Entrepreneurs are willing to take calculated risks to achieve their goals. This includes
financial investments, time commitments, and the possibility of failure. Effective
entrepreneurs assess risks and develop strategies to mitigate them, enabling them to navigate
uncertainty in the business environment.
3. Resource Mobilization:
o Successful entrepreneurship requires the mobilization of various resources, including
financial capital, human talent, and physical assets. Entrepreneurs often seek funding through
investors, loans, or grants and build teams to execute their business plans.
4. Market Understanding:
o An in-depth understanding of the target market is crucial for entrepreneurs. This includes
knowledge of customer needs, industry trends, competitive dynamics, and regulatory
frameworks. Entrepreneurs must conduct market research to inform their strategies and make
informed decisions.
5. Business Planning:
o A well-structured business plan outlines the vision, mission, goals, strategies, and financial
 projections of the new venture. It serves as a roadmap for the entrepreneur, helping to clarify
objectives and attract potential investors or partners.
6. Adaptability:
o The business landscape is constantly evolving, and entrepreneurs must be adaptable to
changing circumstances. This includes being responsive to market feedback, adjusting
business strategies, and pivoting when necessary to seize new opportunities or overcome
challenges.
7. Value Creation:
o At its core, entrepreneurship is about creating value for customers, stakeholders, and society.
This may involve addressing specific problems, enhancing efficiency, or delivering better
solutions than existing offerings.
Types of Entrepreneurship
1. Small Business Entrepreneurship:
o Involves the creation of small enterprises that serve local markets. This can include retail
shops, restaurants, and service providers. Small businesses often focus on steady growth and
community engagement.
2. Scalable Startups:
o These are high-growth ventures that aim to scale rapidly, often in technology or innovative
sectors. They seek significant funding from investors to accelerate growth and capture market
share.
3. Social Entrepreneurship:
o Focuses on creating social or environmental impact while achieving financial sustainability.
Social entrepreneurs develop innovative solutions to address societal challenges, such as
poverty, education, or healthcare.
4. Corporate Entrepreneurship (Intrapreneurship):
o Refers to entrepreneurial activities within established companies. Intrapreneurs drive
innovation and new product development while leveraging the resources and infrastructure of
the parent organization.
5. Franchise Entrepreneurship:
o Involves purchasing the rights to operate a business under an established brand. Franchisees
benefit from the brand’s recognition and support while following the parent company's
business model.
6. Technological Entrepreneurship:
o Emphasizes the development and commercialization of new technologies. Technological
entrepreneurs often work in research and development settings, bringing cutting-edge
 innovations to market.
Importance of Entrepreneurship
1. Economic Growth:
o Entrepreneurship contributes to economic development by creating jobs, increasing
productivity, and fostering innovation. New businesses stimulate competition and drive
economic diversification.
2. Job Creation:
o Startups and small businesses are significant sources of employment. They generate new jobs
and contribute to workforce development.
3. Innovation:
o Entrepreneurs drive technological advancements and creative solutions that address societal
challenges, improving quality of life and enhancing global competitiveness.
4. Community Development:
o Local entrepreneurship fosters community engagement, revitalizes neighborhoods, and
supports social cohesion. Entrepreneurs often invest in their communities, contributing to
local culture and identity.
5. Global Competitiveness:
o Countries with a strong entrepreneurial culture are better positioned to compete in the global
economy. Entrepreneurship encourages adaptability and resilience, essential for navigating
international markets.

ENTREPRENEURSHIP AS A CAREER

Entrepreneurship as a Career
Entrepreneurship as a career offers individuals the opportunity to pursue their passions, create value, and
contribute to economic growth. It encompasses a range of activities related to starting and running a business,
which can vary significantly in scale, industry, and impact. Here’s a comprehensive overview of what
entrepreneurship entails as a career, including its benefits, challenges, necessary skills, and the overall
journey.
Benefits of a Career in Entrepreneurship
1. Autonomy and Flexibility:
o Entrepreneurs have the freedom to make their own decisions, set their own schedules, and
shape the direction of their business. This autonomy can lead to greater job satisfaction and a
more balanced work-life dynamic.
2. Pursuit of Passion:
o Starting a business allows individuals to turn their interests or hobbies into a viable career.
 Entrepreneurs can focus on areas they are passionate about, which can enhance motivation
and fulfillment.
3. Potential for Financial Rewards:
o Successful entrepreneurs can achieve significant financial gains. While starting a business can
be risky, the potential for profit is often greater than in traditional employment.
4. Creativity and Innovation:
o Entrepreneurship fosters creativity and innovation. Entrepreneurs have the opportunity to
develop unique products or services, solve problems in novel ways, and challenge the status
quo.
5. Impact on Society:
o Entrepreneurs can make a meaningful impact by addressing social issues, creating jobs, and
contributing to their communities. Social entrepreneurship, in particular, focuses on
generating positive social or environmental change.
6. Skill Development:
o Entrepreneurs develop a diverse skill set, including leadership, marketing, finance, and
problem-solving. These skills are valuable not only for their business but also in other career
paths.
7. Networking Opportunities:
o The entrepreneurial journey often involves connecting with other business owners, industry
experts, and potential customers. This networking can lead to collaborations, partnerships,
and mentorship.
Challenges of a Career in Entrepreneurship
1. Financial Risk:
o Starting and running a business involves financial investment, which can lead to significant
risk. Entrepreneurs may face uncertainty regarding revenue and expenses, especially in the
early stages.
2. Work-Life Balance:
o Entrepreneurship can demand long hours and significant commitment, making it challenging
to maintain a healthy work-life balance. Entrepreneurs often juggle multiple responsibilities,
especially in the startup phase.
3. Uncertainty and Stress:
o The unpredictable nature of entrepreneurship can lead to stress and anxiety. Entrepreneurs
must be prepared to navigate challenges, setbacks, and failures along the way.
4. Responsibility for All Aspects of the Business:
o Entrepreneurs are often responsible for various functions within their business, including
 marketing, finance, operations, and human resources. This can be overwhelming, especially
for those without experience in certain areas.
5. Competition:
o The business landscape can be highly competitive. Entrepreneurs must differentiate their
products or services and develop effective marketing strategies to attract and retain customers.
6. Regulatory and Compliance Issues:
o Entrepreneurs must navigate legal and regulatory requirements, which can be complex and
time-consuming. Understanding laws related to business registration, taxation, labor, and
industry-specific regulations is essential.
Essential Skills for Entrepreneurs
1. Leadership and Management:
o Strong leadership skills are crucial for motivating and managing teams. Entrepreneurs should
be able to inspire others, delegate tasks, and create a positive company culture.
2. Financial Literacy:
o Understanding financial concepts is vital for managing budgets, cash flow, and profitability.
Entrepreneurs should be able to analyze financial statements and make informed financial
decisions.
3. Marketing and Sales:
o Effective marketing and sales strategies are essential for attracting customers and generating
revenue. Entrepreneurs should be adept at understanding customer needs and developing
compelling value propositions.
4. Problem-Solving and Adaptability:
o Entrepreneurs face numerous challenges that require innovative thinking and quick decision-
making. Being adaptable and open to change is crucial in a rapidly evolving business
environment.
5. Networking and Relationship Building:
o Building a network of contacts, mentors, and advisors can provide valuable support and
resources. Entrepreneurs should be skilled in relationship-building and effective
communication.
6. Strategic Planning:
o Developing a clear business plan and long-term strategy is essential for guiding the direction
of the business. Entrepreneurs should be able to set goals and assess progress regularly.
The Entrepreneurial Journey
1. Idea Generation:
o The entrepreneurial journey begins with identifying a viable business idea or opportunity.
 This may involve market research, brainstorming, and identifying gaps in the market.
2. Business Planning:
o Developing a detailed business plan outlines the vision, target market, business model,
financial projections, and marketing strategies. This plan serves as a roadmap for the business.
3. Funding:
o Entrepreneurs often need to secure funding to launch their business. This can come from
personal savings, loans, angel investors, venture capital, or crowdfunding.
4. Launching the Business:
o Once funding is secured, entrepreneurs can move forward with launching their business. This
involves setting up operations, marketing products or services, and attracting customers.
5. Growth and Scaling:
o Successful entrepreneurs focus on growing and scaling their business. This may involve
expanding product lines, entering new markets, or enhancing operational efficiency.
6. Continuous Learning:
o The entrepreneurial journey is ongoing, requiring continuous learning and adaptation.
Entrepreneurs should seek feedback, stay informed about industry trends, and be willing to
pivot when necessary.
ENTREPRENEURIAL PERSONALITY
Entrepreneurial Personality
An entrepreneurial personality refers to the set of traits, behaviors, and characteristics that are
commonly found in successful entrepreneurs. Understanding these traits can provide insight into
what drives individuals to start and run their own businesses, as well as what contributes to their
success. While not all entrepreneurs will exhibit every trait, several key characteristics are often
associated with entrepreneurial success.
Key Traits of an Entrepreneurial Personality
1. Risk Tolerance:
o Entrepreneurs often embrace risk as a necessary part of their journey. They are
willing to take calculated risks to pursue opportunities, innovate, and achieve their
goals. This trait enables them to navigate uncertainty and make bold decisions.
2. Passion and Drive:
o A strong passion for their business idea or industry motivates entrepreneurs to work
tirelessly and overcome obstacles. Their intrinsic motivation fuels their persistence
and resilience, even in challenging times.
3. Creativity and Innovation:
o Entrepreneurs are typically creative thinkers who can identify problems and develop
innovative solutions. This creativity is essential for designing unique products,
services, or business models that differentiate them from competitors.
4. Visionary Thinking:
o Successful entrepreneurs possess the ability to envision the future and set long-term
goals. They can see opportunities where others may not and have a clear vision of
what they want to achieve, guiding their strategic decisions.
5. Adaptability:
o The ability to pivot and adapt to changing circumstances is crucial for entrepreneurs.
They must be flexible in their approach, able to respond to market feedback, adjust
strategies, and embrace new ideas as they arise.
6. Strong Work Ethic:
o Entrepreneurs often exhibit a high level of dedication and a strong work ethic. They
are willing to put in long hours and make personal sacrifices to achieve their
business objectives.
7. Self-Confidence:
o A healthy level of self-confidence helps entrepreneurs believe in their abilities and
 decisions. This confidence allows them to take risks, inspire others, and persist
through challenges.
8. Leadership Skills:
o Entrepreneurs often take on leadership roles within their organizations. Strong
leadership skills enable them to motivate and manage teams, communicate
effectively, and build a positive organizational culture.
9. Problem-Solving Ability:
o Entrepreneurs face numerous challenges throughout their journey. They are skilled
at identifying problems, analyzing situations, and developing effective solutions
quickly.
10. Networking and Relationship Building:
o Building and maintaining relationships is a key aspect of entrepreneurship.
Entrepreneurs often excel at networking, creating valuable connections with
customers, investors, and mentors, which can provide support and resources.
11. Emotional Resilience:
o The entrepreneurial journey can be filled with ups and downs. Successful
entrepreneurs often display emotional resilience, allowing them to cope with stress,
learn from failures, and maintain a positive outlook.
12. Goal-Oriented:
o Entrepreneurs tend to be highly goal-oriented, setting clear, measurable objectives
for themselves and their businesses. This focus helps them stay motivated and track
progress toward their goals.
The Role of Personality in Entrepreneurship
1. Influence on Business Decisions:
o An entrepreneur's personality can significantly influence their decision-making style.
For instance, risk-tolerant individuals may pursue aggressive growth strategies,
while those who are more cautious may focus on stability and sustainability.
2. Impact on Leadership Style:
o Personality traits shape an entrepreneur's leadership style. For example, a visionary
leader may inspire their team through a compelling vision, while a detail-oriented
leader may focus on operational efficiency.
3. Response to Challenges:
o Different personality traits affect how entrepreneurs respond to challenges and
setbacks. Resilient entrepreneurs are more likely to view failures as learning
 experiences, while those lacking resilience may struggle to recover.
4. Workplace Culture:
o An entrepreneur's personality can influence the culture of their organization. A
positive, open-minded entrepreneur may foster an inclusive and innovative
workplace, while a more authoritarian leader may create a rigid environment.

CHARACTERISTICS OF SUCCESSFUL ENTREPRENEUR

Successful entrepreneurs possess a unique set of characteristics and traits that enable them to navigate
the challenges of starting and running a business effectively. While every entrepreneur is different,
here are some common characteristics that are often associated with successful individuals in this
field:
1. Visionary Thinking:
o Successful entrepreneurs have a clear vision for their business and long-term goals.
They can foresee market trends, identify opportunities, and strategize accordingly to
achieve their objectives.
2. Strong Work Ethic:
o Entrepreneurs often work long hours and are highly dedicated to their ventures. Their
commitment and perseverance are essential for overcoming challenges and driving
their businesses forward.
3. Risk Tolerance:
o A willingness to take calculated risks is a hallmark of successful entrepreneurs. They
understand that risk is inherent in business and are comfortable making decisions that
involve uncertainty.
4. Adaptability:
o The ability to adapt to changing market conditions, customer needs, and unexpected
challenges is crucial. Successful entrepreneurs are flexible and willing to pivot their
strategies when necessary.
5. Creativity and Innovation:
o Entrepreneurs often think outside the box, developing innovative solutions to
problems. Their creativity allows them to differentiate their products or services from
competitors and meet customer demands.
6. Resilience:
o The entrepreneurial journey is often fraught with obstacles and setbacks. Successful
entrepreneurs demonstrate resilience, learning from failures and persisting despite
 challenges.
7. Strong Leadership Skills:
o Effective leaders inspire and motivate their teams. Successful entrepreneurs are skilled
at building strong relationships, delegating tasks, and creating a positive
organizational culture.
8. Excellent Communication Skills:
o Clear and effective communication is vital for entrepreneurs. They need to articulate
their vision, negotiate with partners, and engage with customers, investors, and
employees.
9. Passion and Motivation:
o A genuine passion for their business or industry drives successful entrepreneurs. This
passion fuels their motivation, helping them stay committed and enthusiastic even
during tough times.
10. Financial Acumen:
o Understanding financial management is crucial for success. Successful entrepreneurs
are skilled at budgeting, forecasting, and making informed financial decisions that
support their business growth.
11. Problem-Solving Ability:
o Entrepreneurs regularly face challenges that require quick and effective solutions.
Successful entrepreneurs excel at analyzing problems and developing actionable
strategies to address them.
12. Networking Skills:
o Building and maintaining relationships is essential for entrepreneurship. Successful
entrepreneurs actively network, seeking mentorship, partnerships, and opportunities
that can enhance their business.
13. Goal-Oriented:
o Successful entrepreneurs set clear, measurable goals and work diligently to achieve
them. This focus helps them track progress and maintain motivation over time.
14. Customer-Centric Mindset:
o Understanding and meeting customer needs is a priority for successful entrepreneurs.
They actively seek feedback and use it to refine their offerings and improve customer
satisfaction.
15. Strategic Thinking:
o Entrepreneurs must think strategically about their business direction, market
 positioning, and competitive landscape. Successful entrepreneurs can develop and
execute long-term strategies effectively.
FACTORS AFFECTING ENTREPRENEURIAL GROWTH
Entrepreneurial growth is influenced by a complex interplay of various factors that can either
facilitate or hinder the development of new ventures. Understanding these factors is crucial for
aspiring entrepreneurs, policymakers, and support organizations aiming to foster a vibrant
entrepreneurial ecosystem. Here are the key factors affecting entrepreneurial growth:
1. Economic Factors
• Market Conditions: The overall health of the economy significantly impacts entrepreneurial
growth. A thriving economy often leads to increased consumer demand, investment
opportunities, and access to capital, which can encourage new business formation.
• Access to Finance: Availability of funding sources, including loans, venture capital, and
grants, is critical. Entrepreneurs often require capital to start and grow their businesses, and
limited access can stifle innovation and expansion.
• Infrastructure: Adequate infrastructure, including transportation, communication, and
utilities, facilitates business operations and supports growth. Poor infrastructure can increase
costs and limit market access.
2. Social and Cultural Factors
• Cultural Attitudes: Societal attitudes towards entrepreneurship, risk-taking, and innovation
can influence entrepreneurial activity. Cultures that celebrate entrepreneurship tend to
produce more entrepreneurs and support their ventures.
• Social Networks: Strong networks of support, including mentorship, peer networks, and
community resources, can enhance entrepreneurial growth by providing guidance, resources,
and encouragement.
• Demographics: The characteristics of the population, such as age, education level, and gender,
can influence entrepreneurial activity. For instance, younger populations may be more
inclined to start businesses, while higher education levels can lead to increased innovation.
3. Political and Legal Factors
• Regulatory Environment: Government regulations and policies regarding business formation,
taxation, and employment can significantly impact entrepreneurial growth. A supportive
regulatory environment can facilitate business operations, while excessive bureaucracy can
hinder growth.
• Government Support Programs: Initiatives such as grants, subsidies, tax incentives, and
training programs can encourage entrepreneurship by reducing barriers and providing
 necessary resources.
• Political Stability: A stable political environment fosters investor confidence and encourages
entrepreneurial activity. In contrast, political instability can create uncertainty, deterring
potential entrepreneurs.
4. Technological Factors
• Access to Technology: Availability of advanced technology can enhance productivity, reduce
costs, and enable innovation. Entrepreneurs who can leverage technology effectively are often
better positioned for growth.
• Digital Transformation: The rise of digital platforms and e-commerce has created new
opportunities for entrepreneurs. Businesses that embrace digital tools can reach broader
markets and streamline operations.
5. Educational Factors
• Entrepreneurial Education: Access to education and training programs focused on
entrepreneurship can equip individuals with the skills and knowledge needed to start and
manage a business successfully.
• Skills Development: Continuous skills development, including business management,
financial literacy, and marketing, is essential for entrepreneurs to adapt to changing market
conditions and enhance their competitiveness.
6. Environmental Factors
• Geographical Location: The location of a business can impact access to resources, markets,
and networks. Regions with a strong entrepreneurial ecosystem, such as tech hubs or
innovation districts, tend to foster entrepreneurial growth.
• Natural Resources: Availability of natural resources can influence certain industries,
particularly in sectors like agriculture, mining, and manufacturing, affecting the potential for
entrepreneurial growth.
7. Market Dynamics
• Competition: The level of competition in a market can drive entrepreneurs to innovate and
improve their offerings. While competition can be challenging, it can also lead to new
opportunities for differentiation and growth.
• Consumer Trends: Changes in consumer preferences and trends can create new market
opportunities. Entrepreneurs who can identify and respond to these trends effectively can
achieve significant growth.
ENTREPRENEURIAL MOTIVATION
Entrepreneurial motivation refers to the driving forces behind individuals' decisions to start and
operate their own businesses. Understanding what motivates entrepreneurs is crucial for fostering an
entrepreneurial spirit and supporting the development of new ventures. Here are the key aspects and
sources of entrepreneurial motivation:
1. Intrinsic Motivation
• Passion and Interest: Many entrepreneurs are driven by a genuine passion for their field or
industry. This intrinsic motivation fuels their desire to create and innovate, often leading to
higher levels of commitment and persistence.
• Desire for Autonomy: Entrepreneurs often seek independence and control over their work
lives. The ability to make their own decisions and shape their destinies can be a significant
motivating factor.
• Personal Fulfillment: The opportunity to pursue personal goals, interests, and values can
motivate entrepreneurs. Building something meaningful and making a positive impact can
provide a strong sense of fulfillment.
2. Extrinsic Motivation
• Financial Rewards: The potential for financial success is a significant motivator for many
entrepreneurs. The desire for wealth and financial independence can drive individuals to take
the risks associated with starting a business.
• Recognition and Status: Achieving recognition within a community or industry can be a
motivating factor. Entrepreneurs may strive for status, awards, or accolades that come from
successfully running a business.
• Social Impact: For some entrepreneurs, the motivation comes from the desire to make a
positive impact on society. Social entrepreneurs, in particular, focus on creating solutions to
social issues while generating profit.
3. Fear and Challenges
• Fear of Failure: While fear of failure can be paralyzing for some, it can motivate others to
work harder and succeed. The desire to avoid failure can drive entrepreneurs to plan carefully
and strive for success.
• Desire to Overcome Challenges: The challenges inherent in entrepreneurship can motivate
individuals who thrive on problem-solving and overcoming obstacles. The journey of
building a business can be exhilarating for those who embrace challenges.
4. Influence of Environment
• Supportive Networks: Encouragement from family, friends, mentors, and professional
networks can significantly influence an individual's motivation to pursue entrepreneurship. A
strong support system can provide the confidence and resources needed to take the leap.
 • Role Models: Successful entrepreneurs can serve as role models, inspiring others to follow in
their footsteps. Observing the achievements of others can motivate aspiring entrepreneurs to
pursue their own ventures.
5. Goals and Aspirations
• Setting Personal Goals: Many entrepreneurs are motivated by specific goals, whether
personal, financial, or social. These goals provide direction and purpose, driving them to take
action and stay focused on their journey.
• Vision for the Future: A compelling vision of what they want to achieve can inspire
entrepreneurs. This vision acts as a guiding force, motivating them to persist through
difficulties and work toward long-term success.

COMPETENCIES
Competencies refer to the specific skills, knowledge, and abilities that enable individuals to perform
effectively in a particular role or context. In entrepreneurship, competencies are essential for
navigating the complexities of starting and managing a business. They encompass a range of
functional, technical, and interpersonal skills that contribute to entrepreneurial success. Here are the
key competencies required for entrepreneurs:
1. Technical Competencies
• Industry Knowledge: Understanding the specific industry in which the entrepreneur operates
is crucial. This includes awareness of market trends, key players, regulations, and competitive
dynamics.
• Product Development: Skills in developing, testing, and refining products or services are
essential. Entrepreneurs should understand the processes involved in bringing a product from
concept to market.
2. Business Management Competencies
• Financial Management: Competency in budgeting, forecasting, and financial analysis helps
entrepreneurs manage resources effectively. Understanding financial statements and cash
flow is critical for sustaining the business.
• Marketing and Sales: Skills in market research, branding, promotion, and sales strategies
enable entrepreneurs to effectively reach and engage their target audience.
• Operations Management: Competence in managing day-to-day operations, including supply
chain management, quality control, and logistics, ensures the smooth functioning of the
business.
3. Entrepreneurial Competencies
 • Opportunity Recognition: The ability to identify and evaluate business opportunities is
fundamental. Entrepreneurs must be able to assess market needs and determine how their
offerings can meet those needs.
• Risk Management: Successful entrepreneurs are skilled at assessing and managing risks
associated with starting and running a business. This includes understanding potential pitfalls
and developing strategies to mitigate them.
4. Interpersonal and Leadership Competencies
• Communication Skills: Effective communication is vital for conveying ideas, persuading
stakeholders, and building relationships with customers, employees, and partners.
• Leadership and Team Management: Competency in leading and motivating a team is crucial
for fostering a positive work environment and achieving business goals. This includes
delegating tasks, providing feedback, and nurturing talent.
• Networking Skills: Building and maintaining a network of contacts is important for accessing
resources, knowledge, and support. Networking skills help entrepreneurs connect with
mentors, investors, and collaborators.
5. Strategic Thinking Competencies
• Vision and Strategic Planning: Entrepreneurs need the ability to develop a clear vision for
their business and create strategic plans to achieve their goals. This involves long-term
thinking and anticipating future trends.
• Problem-Solving Skills: Entrepreneurs frequently encounter challenges that require
innovative solutions. Strong problem-solving skills enable them to analyze situations, think
critically, and devise effective strategies.
6. Personal Competencies
• Self-Motivation and Discipline: Successful entrepreneurs are often self-motivated and
disciplined, driving themselves to set and achieve goals without external pressure.
• Adaptability and Resilience: The ability to adapt to changing circumstances and bounce back
from setbacks is essential for navigating the entrepreneurial journey. Resilient entrepreneurs
can maintain focus and motivation despite challenges.
7. Innovation and Creativity Competencies
• Creative Thinking: Entrepreneurs must think creatively to develop unique solutions and
differentiate their products or services from competitors.
• Innovative Mindset: An entrepreneurial mindset encourages continuous improvement and the
exploration of new ideas, fostering innovation within the business.
MOBILITY
Mobility, in the context of entrepreneurship, refers to the ability of entrepreneurs to adapt, move, and
transition across various dimensions, such as geographic locations, markets, and sectors. This concept
encompasses both physical mobility (relocating businesses or operations) and social mobility (the
ability to advance and grow within the entrepreneurial ecosystem). Here are several key aspects of
mobility related to entrepreneurship:
1. Geographic Mobility
• Location Flexibility: Entrepreneurs may need to relocate their businesses to capitalize on new
market opportunities, access resources, or respond to competition. Geographic mobility
allows businesses to thrive in environments that are more conducive to growth.
• Remote Work and Digital Nomadism: Advances in technology have enabled many
entrepreneurs to work remotely. This flexibility can lead to increased productivity and lower
overhead costs while allowing access to global markets.
2. Market Mobility
• Entering New Markets: Entrepreneurs often seek to expand their operations by entering new
markets, both domestically and internationally. Market mobility involves assessing market
conditions, consumer preferences, and regulatory environments to make informed decisions.
• Diversification: By moving into different sectors or offering new products and services,
entrepreneurs can mitigate risks and seize growth opportunities. Diversification allows for
greater resilience in the face of market fluctuations.
3. Social Mobility
• Networking and Relationships: Mobility within the entrepreneurial ecosystem is facilitated
by networking and relationship-building. Entrepreneurs who actively engage with mentors,
investors, and peers can access resources, knowledge, and opportunities that enhance their
growth prospects.
• Access to Funding: Social mobility can impact an entrepreneur's ability to secure funding.
Building relationships with investors and funding organizations can lead to greater access to
financial resources for business development.
4. Skill and Knowledge Mobility
• Continuous Learning: Entrepreneurs must stay adaptable and informed about industry trends,
technologies, and best practices. Mobility in terms of acquiring new skills and knowledge is
crucial for staying competitive.
• Cross-Industry Experience: Entrepreneurs who move between industries can bring diverse
perspectives and innovative approaches to their ventures. This cross-pollination of ideas can
lead to unique solutions and products.
5. Regulatory and Policy Mobility
• Navigating Regulations: Entrepreneurs must navigate different regulatory environments
when moving their businesses or entering new markets. Understanding local laws, permits,
and compliance requirements is essential for successful mobility.
• Influencing Policy: Engaging in advocacy and policy discussions can enable entrepreneurs to
shape regulations that impact their industries. This mobility within the policy landscape can
lead to more favorable conditions for business growth.
ENTREPRENEURSHIP DEVELOPMENT PROGRAMMES
Entrepreneurship Development Programmes (EDPs) are structured initiatives aimed at promoting
and enhancing the skills, knowledge, and capabilities of aspiring and existing entrepreneurs. These
programs are designed to foster entrepreneurial spirit, encourage business creation, and equip
individuals with the necessary tools to succeed in the competitive business landscape. Here’s an
overview of EDPs, their objectives, components, and benefits:
Objectives of EDPs
1. Skill Development: Equip participants with the essential skills required to start and manage a
business, including technical, managerial, and soft skills.
2. Awareness Creation: Raise awareness about entrepreneurship as a viable career option and
the potential benefits of starting a business.
3. Encouraging Innovation: Foster a culture of innovation and creativity among participants,
encouraging them to develop unique business ideas.
4. Access to Resources: Provide access to financial resources, markets, and networks that can
support business growth.
5. Sustainability and Growth: Enable entrepreneurs to develop sustainable business models that
can adapt to changing market conditions.
Components of EDPs
1. Training Workshops: Intensive training sessions focusing on various aspects of
entrepreneurship, including business planning, marketing, financial management, and
operations.
2. Mentorship and Guidance: Providing participants with access to experienced mentors who
can offer advice, share experiences, and help navigate challenges.
3. Networking Opportunities: Facilitating connections between participants, industry experts,
investors, and other stakeholders to enhance collaboration and support.
4. Access to Funding: Providing information about funding options, grants, and subsidies
available for startups and small businesses.
 5. Practical Experience: Encouraging participants to engage in hands-on projects or internships
to gain practical experience in real-world business environments.
Types of EDPs
1. Government Initiatives: Many governments have established EDPs to promote
entrepreneurship, especially among marginalized groups, women, and youth. These programs
often provide financial support, training, and resources.
2. Institutional Programs: Universities, business schools, and training institutes often offer EDPs
as part of their curriculum to develop entrepreneurial competencies among students.
3. Private Sector Programs: Corporations and private organizations may run EDPs aimed at
fostering innovation and entrepreneurship within specific industries or communities.
4. Non-Governmental Organizations (NGOs): NGOs often implement EDPs to empower
underprivileged groups and promote social entrepreneurship.
Benefits of EDPs
1. Enhanced Skills and Knowledge: Participants gain valuable insights and skills that increase
their chances of business success.
2. Increased Confidence: EDPs help individuals build self-confidence and reduce fear of failure,
making them more likely to pursue entrepreneurial ventures.
3. Access to Funding: Participants often gain exposure to funding sources and financial support
options available for startups.
4. Networking: EDPs provide opportunities to connect with like-minded individuals, potential
partners, and industry experts.
5. Promotion of Innovation: By fostering creativity and innovative thinking, EDPs contribute to
the development of new products and services that can drive economic growth.
LAUNCHING OF SMALL ENTERPRISE
Launching a small enterprise involves a systematic approach to transforming an idea into a viable
business. It encompasses several stages, from initial concept development to the establishment of the
business and its operations. Here’s a step-by-step guide to effectively launching a small enterprise:
1. Idea Generation and Research
• Identify Business Idea: Generate and evaluate business ideas based on personal interests,
market needs, and industry trends. Consider what problems your product or service will solve.
• Market Research: Conduct thorough market research to assess demand, target audience, and
competitive landscape. Identify potential customers, their preferences, and pain points.
2. Business Planning
• Develop a Business Plan: Create a comprehensive business plan that outlines your business
 model, target market, competitive strategy, marketing plan, operational plan, and financial
projections. This plan serves as a roadmap for your enterprise.
• Set Goals and Objectives: Define short-term and long-term goals for your business. Ensure
they are SMART (Specific, Measurable, Achievable, Relevant, Time-bound).
3. Legal and Regulatory Considerations
• Choose a Business Structure: Decide on the legal structure of your business (e.g., sole
proprietorship, partnership, limited liability company, corporation) based on factors such as
liability, taxation, and management preferences.
• Register the Business: Register your business with the appropriate government authorities to
obtain necessary licenses and permits. This may include registering a business name,
obtaining an Employer Identification Number (EIN), and complying with local regulations.
• Understand Regulatory Requirements: Familiarize yourself with the regulatory environment
relevant to your industry, including health and safety regulations, environmental laws, and
labor laws.
4. Financial Planning
• Determine Startup Costs: Calculate the initial costs required to launch your business,
including equipment, inventory, office space, marketing, and operational expenses.
• Secure Funding: Explore various funding options, such as personal savings, loans, grants,
angel investors, or venture capital. Prepare to present your business plan to potential investors
or lenders.
5. Location and Infrastructure
• Choose a Location: Select a suitable location for your business based on target market
accessibility, competition, and operational needs. Consider factors like foot traffic, visibility,
and rental costs.
• Set Up Infrastructure: Establish the necessary infrastructure, including office space,
equipment, technology, and inventory management systems. Ensure your business is ready to
operate efficiently from day one.
6. Marketing and Branding
• Develop a Brand Identity: Create a strong brand identity that resonates with your target
audience. This includes choosing a business name, logo, and visual elements.
• Create a Marketing Strategy: Develop a marketing plan to promote your business and attract
customers. Utilize various marketing channels, such as social media, online advertising,
content marketing, and networking.
7. Launch and Operations
 • Set a Launch Date: Choose an appropriate launch date for your business, allowing sufficient
time for preparation and marketing.
• Soft Launch: Consider conducting a soft launch to test your product or service in a smaller
market before a full-scale launch. Gather feedback and make necessary adjustments.
• Official Launch: Execute a formal launch event or campaign to generate excitement and
attract customers. This could include promotional offers, media coverage, or community
events.
8. Monitoring and Evaluation
• Track Performance: Implement metrics to monitor the performance of your business,
including sales, customer feedback, and financial health. Use data analytics tools to gain
insights into customer behavior and operational efficiency.
• Adjust and Improve: Be prepared to adapt your business strategies based on performance data
and market changes. Continuous improvement is key to sustaining growth and success.

DEFINITION, CHARACTERISTICS
Definition of Small and Large Enterprises
Small Enterprises
Definition: Small enterprises, often referred to as small businesses or smes (Small and Medium
Enterprises), are independently owned and operated companies that have a limited number of
employees and relatively low volume of sales. The specific criteria for defining a small enterprise
can vary by country but generally include thresholds related to the number of employees, annual
revenue, and overall size.
Characteristics:
• Limited Scale: Small enterprises typically have fewer than 50 employees (though some
definitions allow up to 250) and a lower volume of sales compared to larger corporations.
• Owner-Operated: They are often owned and managed by a single individual or a small group
of individuals.
• Local Market Focus: Small businesses frequently cater to local or regional markets,
establishing strong relationships with their communities.
• Flexibility: Small enterprises can quickly adapt to changes in market demand or consumer
preferences due to their simpler organizational structures.
• Limited Resources: They usually operate with limited financial and human resources, which
can impact growth and innovation.
Large Enterprises
Definition: Large enterprises are corporations that typically have a significant number of employees
(often over 500) and higher annual revenues. They often operate in multiple markets or regions and
have a complex organizational structure.
Characteristics:
• Scale and Reach: Large enterprises have extensive operations, often spanning multiple
countries and markets, with substantial sales volumes.
• Complex Structure: They usually have multiple layers of management and various
departments specialized in different functions (e.g., marketing, finance, HR).
• Access to Resources: Large businesses generally have greater access to financial capital,
human resources, and technology, allowing for more significant investments in research and
development.
• Brand Recognition: Many large enterprises have well-established brands with significant
market recognition, often enjoying economies of scale.
• Rigidity: Larger organizations may struggle with adaptability due to bureaucratic processes
and slower decision-making.
RELATIONSHIP BETWEEN SMALL AND LARGE UNITS
Relationship Between Small and Large Units
1. Complementary Roles: Small enterprises and large corporations often serve complementary
roles within the economy. Small businesses can provide specialized products and services that
meet niche market demands, while large companies can leverage economies of scale to offer
mass-market products.
2. Supply Chain Dynamics: Small enterprises frequently act as suppliers or service providers to
larger companies. For instance, a small business may supply raw materials or components
that a large manufacturer uses in production.
3. Innovation and Flexibility: Small businesses are often more agile and innovative compared
to larger counterparts. They can quickly pivot to explore new opportunities or develop
creative solutions, which can inspire or influence larger companies.
4. Employment and Economic Growth: Small enterprises play a vital role in job creation and
economic development, often employing a significant portion of the workforce. They
contribute to local economies by generating income and stimulating demand for goods and
services, which benefits larger companies as well.
5. Collaboration and Partnerships: Small and large enterprises may engage in collaborations or
partnerships to leverage each other’s strengths. For example, larger companies may invest in
 or acquire small startups to access innovative technologies or business models.

OPPORTUNITIES FOR AN ENTREPRENEURIAL CAREER

Opportunities for an Entrepreneurial Career
1. Diverse Business Models: Entrepreneurs can explore a wide range of business models, from
traditional brick-and-mortar stores to e-commerce, freelancing, and consultancy. This
diversity allows individuals to choose paths that align with their skills and interests.
2. Emerging Industries: With advancements in technology and changing consumer preferences,
numerous opportunities exist in emerging sectors such as green technology, health and
wellness, digital marketing, and e-learning. Entrepreneurs can capitalize on these trends to
establish successful ventures.
3. Social Entrepreneurship: There is a growing emphasis on social entrepreneurship, where
individuals start businesses to address social issues. Entrepreneurs can create impactful
organizations that contribute to community development while also generating profits.
4. Remote and Freelance Work: The rise of remote work and freelancing platforms has created
new opportunities for entrepreneurs to offer their skills and services without the overhead
costs associated with traditional businesses. This flexibility allows for a more balanced work-
life approach.
5. Global Market Access: The internet has opened up global markets for small enterprises.
Entrepreneurs can reach international customers through online platforms, enabling them to
compete with larger corporations and expand their market reach.
6. Networking and Support: Various programs, incubators, and accelerators provide resources
and support for entrepreneurs. Networking opportunities can lead to collaborations,
mentorship, and access to funding, enhancing the chances of success.
7. Government Initiatives and Funding: Many governments offer incentives, grants, and funding
programs to encourage entrepreneurship, especially in underserved communities.
Entrepreneurs can leverage these resources to start and grow their businesses.
ROLE OF SMALL ENTERPRISE IN ECONOMIC DEVELOPMENT
Small enterprises play a vital role in the economic development of a country. They contribute
significantly to various aspects of the economy, including job creation, innovation, local community
development, and overall economic resilience. Here’s an in-depth look at the various roles small
enterprises play in fostering economic growth:
1. Job Creation
• Employment Opportunities: Small enterprises are major employers in many economies. They
 create a significant number of jobs, often accounting for a large percentage of total
employment. This is especially crucial in developing countries where formal job opportunities
may be limited.
• Diverse Job Profiles: Small businesses offer a variety of job opportunities across different
skill levels, from unskilled labor to professional roles, which helps in utilizing the local
workforce.
2. Contribution to GDP
• Economic Output: Small enterprises contribute substantially to the Gross Domestic Product
(GDP) of a country. They generate income through sales and services, which contributes to
the overall economic activity.
• Sector Diversification: By operating in various sectors (e.g., retail, manufacturing, services),
small businesses enhance economic diversification and reduce dependence on a few large
industries.
3. Innovation and Entrepreneurship
• Fostering Innovation: Small enterprises are often more agile and can adapt quickly to market
changes, leading to higher levels of innovation. They frequently bring new products, services,
and technologies to market.
• Encouraging Entrepreneurship: The presence of small businesses encourages a culture of
entrepreneurship, inspiring others to start their ventures and contribute to economic
dynamism.
4. Local Development and Community Support
• Community Engagement: Small businesses are typically rooted in their local communities.
They often support local causes, participate in community activities, and contribute to the
social fabric of the area.
• Wealth Distribution: By providing employment and generating income, small enterprises help
distribute wealth within the community, contributing to overall economic stability.
5. Flexibility and Resilience
• Adaptability to Change: Small businesses can quickly adapt to economic shifts and consumer
trends, allowing them to remain competitive and resilient during economic downturns.
• Crisis Response: During economic crises, small enterprises often provide essential goods and
services, helping communities navigate challenging times.
6. Export Potential
• Access to Global Markets: Small enterprises can tap into international markets, contributing
to export revenues. Many small businesses produce unique products that appeal to global
 consumers.
• Economic Diversification: By promoting exports, small enterprises help diversify the
economy and reduce vulnerability to local economic fluctuations.
7. Development of Human Capital
• Skill Development: Small enterprises often provide training and development opportunities
for employees, enhancing their skills and employability. This contributes to the overall human
capital development in the region.
• Entrepreneurial Skills: Small business ownership helps develop entrepreneurial skills among
individuals, fostering a culture of self-reliance and innovation.
8. Support for Larger Businesses
• Supply Chain Contributions: Small enterprises often act as suppliers or service providers for
larger companies. They contribute to the overall efficiency and competitiveness of the supply
chain.
• Innovation Partners: Larger firms may collaborate with small businesses for research and
development, leveraging their innovative capabilities to enhance product offerings.
PROBLEMS OF SMALL SCALE INDUSTRIES
Small Scale Industries (ssis) play a critical role in the economic development of many countries, but
they also face several challenges that can hinder their growth and sustainability. Here are some of the
key problems faced by small-scale industries:
1. Access to Finance
• Limited Funding Options: ssis often struggle to access capital due to stringent lending criteria
set by financial institutions. They may lack the necessary collateral, credit history, or financial
statements to secure loans.
• High Interest Rates: Even when funding is available, the cost of borrowing can be
prohibitively high, limiting their ability to invest in growth or improve operations.
2. Technology and Innovation
• Lack of Technological Advancement: Many small industries operate with outdated
technology, leading to inefficiencies and reduced competitiveness. Limited access to modern
technology can hinder production capabilities and innovation.
• Low Research and Development (R&D) Investment: ssis often lack the financial resources to
invest in R&D, resulting in limited innovation and adaptation to market changes.
3. Market Access and Competition
• Market Penetration Challenges: ssis often find it difficult to penetrate larger markets
dominated by established brands and larger companies. This can restrict their growth potential
 and market share.
• Intense Competition: Increased competition from both domestic and international players can
pressure small businesses, making it hard to maintain profitability.
4. Regulatory and Compliance Issues
• Bureaucratic Hurdles: ssis often face complex regulatory frameworks and bureaucratic
processes, making it difficult to comply with licensing, taxation, and other legal requirements.
• Frequent Policy Changes: Changes in government policies and regulations can create
uncertainty for small businesses, making long-term planning challenging.
5. Human Resource Constraints
• Skilled Labor Shortage: ssis often struggle to attract and retain skilled labor due to limited
salaries, training programs, and career advancement opportunities.
• High Employee Turnover: The lack of growth prospects can lead to higher employee turnover
rates, which disrupt operations and increase training costs.
6. Marketing and Branding
• Limited Marketing Budget: Small industries typically have constrained marketing budgets,
making it difficult to promote their products effectively and build brand recognition.
• Lack of Market Knowledge: Many ssis lack the expertise and resources to conduct thorough
market research, which can lead to poor marketing strategies and product positioning.
7. Infrastructure Issues
• Inadequate Infrastructure: Poor infrastructure, such as unreliable transportation, inadequate
power supply, and limited internet connectivity, can hinder the operations and growth of small
industries.
• Location Constraints: Many small businesses are located in less accessible areas, limiting
their market reach and increasing operational costs.
8. Supply Chain Vulnerabilities
• Dependence on Few Suppliers: ssis may rely on a limited number of suppliers for raw
materials, making them vulnerable to supply chain disruptions.
• Inventory Management Challenges: Managing inventory can be difficult for small businesses
due to limited resources and technology, leading to stockouts or excess inventory.
9. Limited Access to Information
• Lack of Awareness of Opportunities: Small entrepreneurs may be unaware of available
resources, government schemes, or market trends that could benefit their businesses.
• Insufficient Networking: Limited opportunities for networking with other businesses,
industry experts, or potential clients can restrict knowledge sharing and collaboration.
INSTITUTIONAL FINANCE TO ENTREPRENEURS
Institutional finance refers to the provision of financial services by organized institutions, such as
banks, financial institutions, venture capital firms, and government agencies. These institutions play
a crucial role in supporting entrepreneurs by providing the necessary funding, expertise, and
resources to help them start and grow their businesses. Here’s an overview of the types of institutional
finance available to entrepreneurs, their significance, and the mechanisms through which they
operate.
Types of Institutional Finance
1. Commercial Banks
o Loans and Overdrafts: Banks provide term loans, working capital loans, and overdraft
facilities to entrepreneurs for various business needs. These loans are typically secured
against collateral and come with fixed or variable interest rates.
o Financial Advice: Many banks offer advisory services to help entrepreneurs manage
their finances effectively, including cash flow management, investment strategies, and
risk assessment.
2. Development Financial Institutions (dfis)
o Long-term Financing: dfis specialize in providing long-term loans to support the
growth of small and medium enterprises (smes). They often focus on sectors that are
essential for economic development.
o Equity Financing: Some dfis also provide equity capital to high-potential startups,
enabling them to scale without taking on excessive debt.
3. Venture Capital (VC) Firms
o Equity Investment: VC firms invest in startups and early-stage companies in exchange
for equity stakes. They typically focus on high-growth sectors such as technology,
biotechnology, and clean energy.
o Mentorship and Networking: In addition to funding, VC firms often provide strategic
guidance, mentorship, and access to a network of industry contacts, which can be
invaluable for entrepreneurs.
4. Angel Investors
o Seed Funding: Angel investors are high-net-worth individuals who invest their
personal funds in startups, often at the early stages of development. They provide
capital in exchange for equity or convertible debt.
o Expertise and Networking: Beyond financial support, angel investors can offer
mentorship and guidance based on their own entrepreneurial experiences.
 5. Microfinance Institutions (mfis)
o Small Loans: mfis provide small loans to entrepreneurs, especially in underserved
communities, enabling them to start or expand their businesses. These loans often
have lower collateral requirements and interest rates compared to traditional banks.
o Financial Literacy Programs: Many mfis also offer training programs to enhance the
financial literacy of their clients, helping them manage their businesses effectively.
6. Government Schemes and Programs
o Subsidized Loans and Grants: Governments often implement various schemes to
promote entrepreneurship by offering subsidized loans, grants, and tax incentives.
These programs aim to reduce the financial burden on startups and encourage
innovation.
o Incubators and Accelerators: Some government initiatives support incubators and
accelerators that provide funding, mentoring, and resources to early-stage startups.
7. Crowdfunding Platforms
o Public Funding: Entrepreneurs can raise funds through crowdfunding platforms by
soliciting small contributions from a large number of people. This method allows
businesses to validate their ideas and build a customer base before launching their
products.
o Equity Crowdfunding: Some platforms enable entrepreneurs to offer equity stakes in
their companies in exchange for investments, similar to venture capital.
Significance of Institutional Finance for Entrepreneurs
1. Access to Capital: Institutional finance provides entrepreneurs with the capital needed to start,
operate, and expand their businesses. This access is critical for covering initial startup costs,
purchasing equipment, and hiring staff.
2. Risk Mitigation: By leveraging institutional financing, entrepreneurs can mitigate personal
financial risk. Instead of using personal savings or loans from friends and family, they can
secure funds from reputable institutions.
3. Growth Opportunities: With access to institutional finance, entrepreneurs can seize growth
opportunities, such as entering new markets, developing new products, or investing in
technology.
4. Expertise and Support: Many financial institutions offer additional services beyond funding,
such as business advice, mentoring, and networking opportunities, which can significantly
enhance an entrepreneur’s chances of success.
5. Encouragement of Innovation: Institutional financing often focuses on high-potential and
 innovative startups, helping to foster an entrepreneurial ecosystem that encourages creativity
and technological advancement.
INSTITUTIONAL SUPPORT TO ENTREPRENEURS.
Institutional support refers to the various services, resources, and assistance provided by
organizations—both governmental and non-governmental—that aim to foster entrepreneurship and
promote the growth of small and medium enterprises (SMEs). This support can take various forms,
including financial assistance, mentorship, infrastructure development, policy advocacy, and capacity
building. Below are the key areas of institutional support available to entrepreneurs:
1. Financial Support
• Grants and Subsidies: Many government and non-governmental organizations offer grants or
subsidies to entrepreneurs to help them start or expand their businesses. These funds often do
not require repayment, making them a valuable resource for new ventures.
• Low-Interest Loans: Financial institutions, including banks and microfinance institutions,
provide loans with lower interest rates and favorable terms to promote entrepreneurship.
• Venture Capital and Angel Investment: Institutional investors like venture capital firms and
angel investors provide equity financing to startups in exchange for ownership stakes, helping
them scale without incurring debt.
2. Business Incubators and Accelerators
• Startup Incubators: These are organizations designed to support startups in their early stages
by providing resources such as office space, mentorship, and access to funding. They help
entrepreneurs refine their business models and prepare for market entry.
• Accelerators: Similar to incubators, accelerators offer intense, time-bound support programs
that focus on rapid growth. They often culminate in a "demo day," where startups pitch to
potential investors.
3. Mentorship and Advisory Services
• Business Mentorship Programs: Many organizations connect entrepreneurs with experienced
business leaders who provide guidance, advice, and support. This mentorship can be
invaluable for navigating the complexities of starting and running a business.
• Advisory Services: Institutions may offer professional advisory services to assist with
business planning, marketing strategies, legal compliance, and operational management.
4. Training and Capacity Building
• Workshops and Seminars: Various institutions provide training programs aimed at enhancing
entrepreneurial skills, such as financial management, marketing, business development, and
technology usage.
 • Online Courses and Resources: Many organizations offer free or low-cost online resources
and courses that entrepreneurs can access to build their knowledge and skills at their
convenience.
5. Networking Opportunities
• Business Networking Events: Institutions often organize networking events, trade shows, and
conferences to facilitate connections among entrepreneurs, investors, and industry experts,
helping to build relationships and opportunities for collaboration.
• Industry Associations: Joining industry-specific associations can provide entrepreneurs with
access to a broader network of contacts, resources, and best practices.
6. Infrastructure Development
• Industrial Parks and Clusters: Governments may establish industrial parks or clusters where
entrepreneurs can access shared facilities, resources, and support services, thus reducing
operational costs.
• Technology Hubs: Initiatives to create technology parks or hubs can provide startups with
access to state-of-the-art infrastructure, research facilities, and support from academic
institutions.
7. Policy and Regulatory Support
• Simplification of Regulatory Processes: Governments can streamline business registration
processes, reduce bureaucratic hurdles, and create a more business-friendly regulatory
environment to encourage entrepreneurship.
• Advocacy for Entrepreneurial Policies: Institutions can advocate for policies that support
entrepreneurship, such as tax incentives, reduced regulatory burdens, and support for research
and development.
8. Access to Markets
• Market Research and Intelligence: Institutions may provide access to market research data
and intelligence to help entrepreneurs make informed decisions about product development
and market entry.
• Trade Facilitation: Support in export promotion, trade fairs, and international collaborations
can help entrepreneurs access larger markets beyond their local areas.